Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,19764,99,0.51 [0.18-1.47],0.2141655837067725
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,19233,94,0.85 [0.59-1.24],0.3998902396213176
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,22564,113,0.91 [0.68-1.23],0.5505063904885967
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,19133,94,1.44 [0.89-2.33],0.1406358911212188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,22434,108,0.87 [0.65-1.17],0.3511120578256829
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,22564,113,0.93 [0.72-1.20],0.5767852186446976
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,19739,99,0.98 [0.86-1.12],0.7401023494220158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,19133,94,0.96 [0.71-1.29],0.775548411494952
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",22152,109,0.98 [0.79-1.21],0.8354737635206116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",19353,94,0.88 [0.65-1.20],0.42508680944306
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",19732,96,0.91 [0.73-1.14],0.4149310818198787
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,22464,114,0.66 [0.37-1.20],0.1730000446545127
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,19739,99,1.51 [0.74-3.08],0.2550749050285067
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,22266,114,1.33 [1.00-1.78],0.0523605510016145
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,19322,96,1.25 [0.70-2.23],0.4500110652722694
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,19632,95,0.98 [0.82-1.17],0.8286787128624894
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,22670,116,1.09 [0.80-1.50],0.5733934121532296
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,19188,99,0.84 [0.54-1.32],0.4557940213323185
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,22779,117,1.50 [0.98-2.29],0.0616420472449748
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,22829,114,1.18 [0.91-1.54],0.2189292419381713
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,19627,96,1.36 [0.86-2.16],0.191699494070955
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,19188,99,1.10 [0.64-1.88],0.7227773458967393
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,19133,94,0.57 [0.30-1.11],0.098920640984072
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",22266,114,1.36 [0.99-1.87],0.0549448506094104
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,19133,94,1.28 [0.92-1.77],0.1455867512319884
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,22241,113,1.03 [0.62-1.74],0.9000260002237539
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,22479,109,1.95 [1.00-3.79],0.0493462266166814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,22670,116,1.13 [0.87-1.48],0.3597257405579367
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,19133,94,1.09 [0.76-1.55],0.6451972702784299
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,19239,96,1.08 [0.80-1.44],0.6175143691173313
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,22918,116,0.99 [0.61-1.59],0.9541661786560756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,22514,117,0.95 [0.64-1.41],0.8137459661233097
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19188,99,1.31 [0.79-2.17],0.3018320850294347
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22266,114,0.92 [0.53-1.59],0.7587367678766664
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,22514,109,1.23 [0.75-2.00],0.4124524906526836
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,22918,116,0.86 [0.55-1.34],0.5044094666492801
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,22828,115,0.72 [0.41-1.27],0.2577546052303894
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,19632,95,1.42 [0.75-2.69],0.2755647708993946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,19188,99,1.47 [0.90-2.40],0.1251949929865652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,22941,117,0.62 [0.31-1.24],0.1767368989419876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,22564,113,1.47 [0.98-2.22],0.0649173495183702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,22266,114,1.10 [0.67-1.80],0.7033084400084169
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,19188,99,1.53 [0.92-2.54],0.0996724033490763
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,22740,117,1.09 [0.76-1.58],0.6326360672378357
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,19730,98,2.00 [1.14-3.52],0.0163232339583913
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,19233,94,1.57 [0.67-3.69],0.3038923032231185
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,19732,96,1.03 [0.62-1.70],0.918516117566649
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,22152,109,0.85 [0.49-1.49],0.5753651240493041
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,19322,96,0.99 [0.75-1.30],0.9302586969499592
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,22479,109,1.28 [0.77-2.12],0.3397284933475434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,19322,96,2.39 [1.47-3.91],0.0004851202937249
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,19632,95,1.06 [0.74-1.52],0.7557491474456091
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,22774,117,0.87 [0.48-1.58],0.6495556592717824
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,22833,116,0.85 [0.48-1.49],0.5718476674937738
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,19732,96,1.08 [0.56-2.06],0.8204732405711651
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,22564,113,1.01 [0.76-1.34],0.9318566293867984
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,22670,116,0.55 [0.30-1.01],0.0528686855317139
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,19124,93,0.99 [0.75-1.31],0.9423570575836068
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,19322,96,0.96 [0.73-1.26],0.758761966422157
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22266,114,1.01 [0.83-1.24],0.9007255525717224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,19764,99,0.90 [0.68-1.19],0.4611203704490116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,22868,114,1.57 [0.82-3.00],0.1696487040642007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,19133,94,0.89 [0.66-1.21],0.4679190672902682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,19322,96,0.88 [0.70-1.12],0.3032748953017052
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AFM,Afamin,19764,99,1.16 [0.42-3.24],0.7779819932081016
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,22452,109,1.07 [0.83-1.36],0.6170630839102895
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,19124,93,1.08 [0.86-1.36],0.5044652330706276
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,22620,115,0.90 [0.60-1.35],0.619724310037408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,21907,110,1.06 [0.90-1.25],0.4924644588014351
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,22112,109,1.03 [0.78-1.37],0.8203339395927829
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,22774,117,1.79 [1.14-2.80],0.0110547744838888
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,22918,116,1.14 [0.83-1.57],0.427337156587556
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,19739,99,1.02 [0.46-2.29],0.958070152955968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,22670,116,1.05 [0.85-1.30],0.6250041081207356
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,22670,116,1.04 [0.82-1.32],0.7368740966785563
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,19233,94,0.49 [0.25-0.97],0.0392228067480597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,19233,94,1.42 [0.74-2.72],0.2960981017520369
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,19627,96,0.89 [0.65-1.22],0.4584815250101043
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,19739,99,1.00 [0.50-2.00],0.9923830514774972
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,22644,117,0.96 [0.79-1.16],0.6604024596179279
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",19186,95,1.08 [0.87-1.33],0.4914435776166482
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,22152,109,0.80 [0.57-1.11],0.1839406233220484
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,19233,94,1.34 [1.04-1.73],0.0216851062403344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",22518,112,1.06 [0.91-1.24],0.4484830612704376
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,22670,116,0.83 [0.64-1.07],0.1557789815701218
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",19693,96,1.02 [0.85-1.22],0.8393795956008162
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,19322,96,2.26 [1.45-3.52],0.0003310907973944
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,22152,109,0.94 [0.74-1.18],0.5677453761666519
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,19186,95,1.49 [1.17-1.90],0.0011117042776946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,22266,114,0.88 [0.63-1.23],0.4698835952836507
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,19188,99,1.01 [0.77-1.34],0.916450533898546
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,22105,111,0.98 [0.76-1.26],0.8745151387672336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,19702,96,0.98 [0.84-1.15],0.8359233013032391
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,22043,108,1.02 [0.75-1.38],0.9121808682769216
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,22941,117,0.88 [0.38-2.05],0.7607058982428421
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,22679,117,0.96 [0.71-1.30],0.7871361190050373
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",19627,96,1.09 [0.78-1.52],0.6232487186415245
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",22595,113,1.30 [1.07-1.57],0.008578618158705
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",19702,96,0.88 [0.57-1.35],0.5631674545783445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,19353,94,0.95 [0.62-1.47],0.8217711774412637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,19188,99,1.01 [0.86-1.18],0.8908857177494345
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",22564,113,1.22 [1.05-1.43],0.0114366397915705
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,22241,113,0.73 [0.37-1.45],0.3684779323140075
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,22835,114,1.07 [0.47-2.46],0.8658077137188873
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,19730,98,1.92 [0.93-3.97],0.0770964567587919
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,22105,111,1.12 [0.88-1.43],0.3637316879918909
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,19186,95,0.65 [0.39-1.06],0.0860013392168219
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,22564,113,1.13 [0.54-2.34],0.7521929329724597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,22241,113,1.15 [0.81-1.61],0.4363636629583491
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,19322,96,1.04 [0.64-1.69],0.8809849856179108
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,19568,95,0.85 [0.55-1.33],0.476858961665903
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,19693,96,1.01 [0.77-1.31],0.958112705981705
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,18467,93,0.95 [0.64-1.43],0.8180947824971789
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,21770,112,1.01 [0.71-1.44],0.9559254929986022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,21114,109,1.02 [0.71-1.46],0.9174323044655072
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,22589,118,1.39 [0.88-2.19],0.1588537048371691
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,22590,115,0.99 [0.82-1.20],0.92682107279406
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,22868,114,1.26 [0.82-1.94],0.2896885819158187
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,22365,115,2.08 [1.19-3.64],0.0099870077919363
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,22706,116,0.94 [0.63-1.41],0.7626884837666865
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,22657,118,1.14 [0.73-1.78],0.571981262774014
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,22734,116,1.39 [0.96-2.00],0.0783041002221517
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,22868,114,1.38 [0.88-2.16],0.1554692282747887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,19133,94,1.06 [0.82-1.36],0.6652540281934936
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,19188,99,0.93 [0.73-1.19],0.5770650345895632
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,19040,95,1.24 [0.92-1.66],0.1616254214888969
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,22152,109,0.69 [0.49-0.97],0.0350132058762222
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,19233,94,1.37 [0.98-1.92],0.0677443067300148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,22693,118,0.61 [0.33-1.11],0.1067303816297025
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,19197,96,1.25 [0.86-1.83],0.2436870830342931
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,22105,111,1.15 [0.96-1.38],0.1326392146836011
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,22598,113,0.89 [0.70-1.13],0.3270007734857195
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,18941,93,1.03 [0.78-1.36],0.846074171371925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,22828,115,1.06 [0.84-1.34],0.6295619249070384
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,22554,116,0.95 [0.76-1.20],0.6700795873998224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,22045,111,0.79 [0.44-1.41],0.4248760914147663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],22241,113,1.05 [0.80-1.38],0.7348519289955412
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,22734,118,1.34 [0.78-2.31],0.2864180613596372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,19627,96,0.90 [0.70-1.16],0.4298894711190527
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,19186,95,0.84 [0.54-1.29],0.4173565170095795
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,19632,95,0.91 [0.70-1.18],0.4811244703226115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,19693,96,0.90 [0.59-1.38],0.6230220651420113
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,22564,113,0.78 [0.52-1.18],0.2374364672428407
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,19583,99,0.76 [0.45-1.29],0.3122757895786463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,22795,114,0.87 [0.65-1.16],0.3505293743347338
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,22670,116,0.85 [0.61-1.16],0.3029163090290937
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,19764,99,0.80 [0.38-1.70],0.5596857055445271
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,19739,99,1.15 [0.77-1.70],0.4973401498110578
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,19764,99,0.85 [0.48-1.49],0.5652746889048997
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,19739,99,1.10 [0.47-2.55],0.8269401600973619
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,19233,94,0.70 [0.45-1.09],0.1112713704796366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,19720,99,0.59 [0.33-1.06],0.0769873685647067
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,18850,95,0.86 [0.51-1.46],0.5749328077000139
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,19764,99,1.01 [0.78-1.31],0.9457499516270798
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,19739,99,0.62 [0.41-0.94],0.0247109744244301
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,22679,117,0.85 [0.53-1.35],0.4886536199778667
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,19739,99,0.73 [0.51-1.04],0.0811769079462046
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,22697,118,0.48 [0.27-0.85],0.012766217901511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,22645,117,1.01 [0.79-1.29],0.9366093218688252
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,19322,96,0.97 [0.82-1.16],0.7584191632928542
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,22484,109,0.98 [0.69-1.39],0.8985331528943926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,19353,94,0.79 [0.58-1.08],0.1436932414361456
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,22564,113,1.37 [0.98-1.90],0.0650434728531815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,19632,95,0.89 [0.74-1.06],0.1948168859558724
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,19702,96,0.90 [0.67-1.19],0.4494625401936327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,22572,113,0.82 [0.60-1.12],0.2134819412298925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",19627,96,1.06 [0.70-1.63],0.7728584596431586
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,22152,109,0.84 [0.58-1.21],0.3446420978609316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,22152,109,0.92 [0.68-1.25],0.5981044468930454
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,19353,94,0.98 [0.58-1.66],0.9488451630326572
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,19322,96,0.97 [0.76-1.24],0.8080517373218704
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,19040,95,1.18 [0.95-1.46],0.1423485640117666
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,19693,96,0.95 [0.77-1.18],0.6553724943229966
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,19702,96,0.94 [0.76-1.16],0.5368797554402155
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,22628,113,0.97 [0.83-1.14],0.6973181182803341
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,19124,93,0.85 [0.64-1.15],0.2980484395235673
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,19124,93,0.83 [0.49-1.41],0.4862873589647726
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,22105,111,0.71 [0.44-1.16],0.1703655357018669
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,19133,94,1.01 [0.76-1.34],0.9379716501945344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,19133,94,0.93 [0.57-1.52],0.7708951395197006
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,19124,93,0.98 [0.72-1.34],0.9140578207603628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,22241,113,1.20 [0.79-1.82],0.4048976543271022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,19133,94,1.03 [0.72-1.47],0.8796415838427747
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,22679,117,1.40 [0.99-1.99],0.0582738635820399
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,22564,113,1.06 [0.78-1.44],0.7012333510601805
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,22734,118,0.82 [0.50-1.35],0.4432932232299007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,19124,93,0.75 [0.50-1.13],0.1761372841686066
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,22241,113,1.19 [0.89-1.58],0.2410115448357638
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,19547,98,1.00 [0.66-1.52],0.9941889236318936
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,22514,109,0.93 [0.68-1.27],0.639413477791881
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,22514,109,2.23 [1.30-3.81],0.0035726773469863
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,19739,99,1.65 [0.81-3.34],0.1676813390577273
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,19732,96,1.49 [0.83-2.65],0.1821324280765722
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,19702,96,0.92 [0.69-1.23],0.5898091239707859
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,19233,94,0.89 [0.73-1.08],0.2192151872682032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,19133,94,0.89 [0.69-1.16],0.3954446627014608
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,22105,111,1.11 [0.90-1.37],0.3171768710535597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,19040,95,1.29 [0.78-2.16],0.3246456308209137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,19632,95,0.93 [0.73-1.17],0.5212116315216586
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,22152,109,0.89 [0.67-1.19],0.4502837051368322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,22740,117,0.92 [0.73-1.15],0.4644994606260787
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,19133,94,1.35 [1.03-1.77],0.0276045896168561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,19133,94,1.29 [0.72-2.32],0.3881031962526398
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,19133,94,1.32 [0.87-2.00],0.1935093029437158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,19040,95,1.45 [1.00-2.09],0.0508964830052935
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,19133,94,1.14 [0.87-1.49],0.3376557443538265
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",19133,94,1.29 [1.05-1.59],0.0164964458373542
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",22774,117,0.99 [0.86-1.15],0.9019427765866496
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",22105,111,1.30 [0.92-1.83],0.1338091594568867
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,22152,109,0.87 [0.55-1.35],0.5262929874984952
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,22564,113,0.67 [0.34-1.34],0.2579665495187847
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,22056,110,0.88 [0.67-1.14],0.3256934895027127
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,19233,94,0.86 [0.65-1.15],0.3118635545827435
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,19133,94,0.86 [0.69-1.06],0.15406347626511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,19632,95,1.33 [0.83-2.12],0.2303833239392307
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",19764,99,0.60 [0.19-1.90],0.3897354714011986
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,22105,111,0.96 [0.76-1.21],0.7495486223519136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,19124,93,1.01 [0.85-1.20],0.8834551344584741
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,19702,96,1.34 [0.94-1.91],0.1077364773374739
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,19693,96,0.91 [0.67-1.24],0.5518954425542177
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,22628,113,0.99 [0.83-1.18],0.8954065202013055
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,22734,118,1.08 [0.60-1.97],0.7939957632628255
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,19702,96,0.88 [0.61-1.26],0.4845173257537905
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,21947,111,0.98 [0.79-1.22],0.8500137664059748
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,19764,99,1.26 [0.80-1.99],0.3222818008206702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,19133,94,0.89 [0.33-2.41],0.8176350185196388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19233,94,1.28 [0.74-2.22],0.385102540485886
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",22774,117,1.54 [0.85-2.79],0.1539248861057567
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",22679,117,0.79 [0.40-1.57],0.5025446330284187
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,19188,99,1.20 [0.64-2.25],0.559680966398574
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,22628,113,1.03 [0.82-1.29],0.8212955410468791
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,22479,109,1.03 [0.67-1.58],0.8978746644318281
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,19188,99,1.23 [0.85-1.77],0.2703832582061465
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,22266,114,1.02 [0.65-1.63],0.9173001345616074
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22152,109,1.11 [0.85-1.44],0.4603448907113815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,22152,109,1.33 [0.76-2.31],0.3175516875645403
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,22628,113,1.00 [0.85-1.17],0.9612884901821998
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,19693,96,1.03 [0.78-1.37],0.815741117946373
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,19186,95,0.94 [0.74-1.21],0.6397277670584182
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,22075,111,1.05 [0.87-1.27],0.6162434462198996
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,22679,117,1.08 [0.54-2.15],0.8373760640959446
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,22514,109,0.85 [0.52-1.39],0.515022379207727
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",19732,96,1.26 [0.69-2.27],0.4518808738482274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",19124,93,0.88 [0.59-1.31],0.5221775092126282
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,19367,99,0.93 [0.48-1.80],0.8265095989533927
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,19632,95,0.94 [0.64-1.38],0.7582795320649891
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,19693,96,1.02 [0.83-1.24],0.8811338722972766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",22628,113,1.03 [0.71-1.50],0.8797280838852217
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,19188,99,0.98 [0.70-1.36],0.8885818831707892
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,19040,95,0.83 [0.59-1.18],0.3027922431175314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,19627,96,1.15 [0.78-1.71],0.4810267757329984
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,22628,113,1.01 [0.84-1.21],0.9344971870857448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,19730,98,0.92 [0.74-1.16],0.4863457105913233
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,19233,94,0.80 [0.57-1.12],0.1899314400090006
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,19040,95,1.09 [0.74-1.61],0.6634555601392147
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,19730,98,0.95 [0.77-1.18],0.6437565461094562
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,22112,108,1.08 [0.94-1.24],0.2592688465336993
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,19124,93,1.00 [0.76-1.32],0.9841032741167908
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,19133,94,1.16 [0.53-2.54],0.7030881929241689
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,22628,113,0.99 [0.77-1.26],0.921156755145278
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,22679,117,0.91 [0.76-1.09],0.3286799625944525
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,22152,109,0.93 [0.71-1.22],0.6075397446430503
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,22941,117,0.93 [0.57-1.53],0.7748462819978923
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,19188,99,1.48 [0.99-2.21],0.0537053543304509
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,19124,93,1.11 [0.88-1.42],0.3780976354393653
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,19693,96,0.88 [0.53-1.46],0.6286060259618782
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,22679,117,0.91 [0.71-1.17],0.4714630685900322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,19322,96,1.14 [0.57-2.26],0.715628538515928
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,22479,109,1.03 [0.71-1.50],0.8677503464401874
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,22230,114,1.19 [0.79-1.78],0.4027730865436945
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,19322,96,2.99 [1.84-4.88],1.1260091813444928e-05
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,19732,96,1.22 [0.71-2.10],0.4691340035668989
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,19188,99,1.16 [0.76-1.76],0.4992785546488123
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,22266,114,1.58 [0.78-3.20],0.2028582229623254
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,19124,93,1.25 [0.91-1.71],0.1723419779346501
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,19233,94,0.90 [0.63-1.29],0.5746999217104647
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,18549,90,0.97 [0.80-1.17],0.7199692957428179
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,22609,113,1.03 [0.79-1.36],0.8113971899313174
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,19698,96,1.05 [0.79-1.38],0.7423828496478734
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,19462,95,0.92 [0.77-1.10],0.3855336181368065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,19353,94,0.52 [0.25-1.09],0.0826813503493543
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,19124,93,0.88 [0.47-1.64],0.6896362380296954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,19133,94,1.14 [0.81-1.62],0.4464129294053717
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,19133,94,1.47 [0.89-2.41],0.1309632307986887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,22105,111,0.82 [0.55-1.21],0.3161383941218975
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,19124,93,0.62 [0.34-1.11],0.1044616937843821
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,19702,96,0.82 [0.49-1.38],0.4662381093150557
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BSG,Basigin,22878,116,1.68 [0.73-3.88],0.2244439772864351
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BSND,Barttin,19040,95,1.30 [0.80-2.11],0.2956284907539835
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,22868,115,0.84 [0.62-1.13],0.240700333385652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,22868,115,1.20 [0.90-1.58],0.2113258438842722
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,22152,109,0.92 [0.73-1.17],0.4957633828513057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,19764,99,0.57 [0.24-1.38],0.2141539168529828
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,19040,95,1.06 [0.86-1.31],0.5765031359041587
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,19592,96,1.04 [0.66-1.63],0.8746056750234712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,22774,117,1.10 [0.58-2.07],0.7722669913901935
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,22628,113,1.68 [1.16-2.43],0.0056979558234001
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,19040,95,0.89 [0.53-1.49],0.6610906575693398
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,22105,111,1.06 [0.82-1.38],0.6647434360947919
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,19133,94,1.34 [0.75-2.38],0.3218718462984324
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,22801,116,0.99 [0.47-2.06],0.9703492613280608
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",19702,96,1.04 [0.82-1.33],0.7372762709278646
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,19188,99,1.02 [0.66-1.57],0.937810585997268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,22734,118,0.89 [0.61-1.30],0.5426234637714848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,19322,96,1.97 [1.16-3.35],0.0123926725164872
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,19702,96,1.02 [0.56-1.84],0.9540216203370204
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19280,96,1.53 [0.98-2.38],0.0603694885588749
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,19764,99,0.55 [0.17-1.80],0.3223831207926667
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,19732,99,1.06 [0.39-2.85],0.9080910279231302
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,19764,99,0.67 [0.27-1.69],0.4010764199236121
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C2,Complement C2,22697,118,0.86 [0.46-1.60],0.6335786607940537
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,22056,110,1.10 [0.75-1.60],0.626651295329208
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,19186,95,1.04 [0.76-1.44],0.7890254422974997
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C3,Complement C3,18756,94,0.95 [0.61-1.49],0.8300290192474072
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,22740,117,0.92 [0.62-1.37],0.6922385674510589
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C5,Complement C5,19764,99,1.68 [0.56-5.08],0.3553613919973138
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,19288,98,2.07 [1.10-3.92],0.0250327546916537
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,19693,96,0.81 [0.30-2.14],0.6629791703197951
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,19764,99,0.89 [0.48-1.67],0.7278804777808334
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,19739,99,0.80 [0.55-1.16],0.2431194212546915
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,19632,95,0.96 [0.76-1.21],0.7265727867611821
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,22139,117,0.84 [0.64-1.09],0.1825083339712374
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,22152,109,0.93 [0.53-1.61],0.7846619205851133
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,22564,113,1.45 [0.87-2.40],0.1543125658528345
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,22430,114,0.99 [0.84-1.16],0.8975738265971356
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,22868,114,0.83 [0.51-1.35],0.4471806641618348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,22603,117,0.93 [0.74-1.17],0.5522662693628304
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,22902,117,0.88 [0.67-1.15],0.3528967495509751
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,22941,117,1.37 [0.69-2.75],0.369479268231737
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",22266,114,1.00 [0.83-1.19],0.9609216957814056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,22606,116,1.03 [0.79-1.33],0.8457925422911887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,19353,94,0.71 [0.38-1.33],0.2786938426525248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,19188,99,1.30 [0.79-2.13],0.2980735334109257
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,22868,114,1.16 [0.82-1.64],0.4082939592078128
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,19186,95,0.96 [0.71-1.31],0.7953701995265017
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,19124,93,0.66 [0.33-1.32],0.2366661082706945
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,19133,94,1.00 [0.72-1.39],0.9980477173342136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,19124,93,1.03 [0.75-1.42],0.8505743510410975
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,19702,96,0.98 [0.78-1.23],0.8510695527263652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,19279,96,1.04 [0.86-1.26],0.6709983051269239
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,19186,95,0.98 [0.62-1.55],0.9288764318878492
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,22564,113,1.27 [0.85-1.90],0.249803690696054
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,22105,111,0.87 [0.49-1.54],0.6317666560781628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,22465,108,1.20 [0.91-1.60],0.2013221480766602
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,19693,96,1.14 [0.72-1.81],0.562326128948837
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,22795,114,0.95 [0.81-1.12],0.5704088062127304
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,19233,94,0.89 [0.69-1.16],0.3858512658930103
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,19133,94,1.50 [1.08-2.08],0.0148913051417409
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,22152,109,1.18 [0.81-1.72],0.3962506896957201
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,19186,95,0.91 [0.63-1.32],0.6203728580890413
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,19702,96,0.87 [0.72-1.04],0.1297427776041005
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,22604,116,1.35 [0.60-3.03],0.4722990960894773
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,22514,113,0.95 [0.71-1.27],0.7384988662960061
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,19627,96,1.29 [0.85-1.95],0.2275762896240905
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,19693,96,1.11 [0.95-1.30],0.1865606887589208
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,22105,111,0.77 [0.55-1.07],0.1243798282664859
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,19186,95,1.14 [0.72-1.83],0.5748458420681783
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,22105,111,0.83 [0.64-1.07],0.1550051667413036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,22105,111,1.09 [0.86-1.38],0.4919624225036341
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,22628,113,1.00 [0.79-1.28],0.9775353079515028
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,22941,117,1.02 [0.85-1.23],0.8519878690965428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,19353,94,1.01 [0.90-1.13],0.8634521211748338
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,19693,96,0.97 [0.77-1.23],0.7990849748630454
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,22796,114,0.84 [0.64-1.11],0.2256647713557358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,19188,99,1.24 [0.93-1.64],0.1390069480886323
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,19133,94,1.13 [0.79-1.62],0.5045058846676725
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAT,Catalase,19434,96,0.96 [0.68-1.38],0.8402063093062875
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,22636,116,0.92 [0.75-1.14],0.4506100859339829
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,19124,93,0.77 [0.58-1.02],0.064578742702059
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,22868,114,0.78 [0.46-1.33],0.3687639872108892
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,19233,94,1.09 [0.75-1.59],0.6591890009369251
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,19133,94,1.08 [0.69-1.68],0.7425748994381278
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,22514,109,0.92 [0.73-1.16],0.4655051350687746
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,19693,96,1.00 [0.70-1.41],0.981347642321418
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,19627,96,1.38 [0.98-1.94],0.0629717291562029
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,19186,95,1.89 [0.97-3.69],0.0616561704282717
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,19702,96,1.02 [0.80-1.30],0.8880842119511521
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,22670,116,1.23 [0.79-1.93],0.3554474829720166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19233,94,1.15 [0.85-1.57],0.3653578458662103
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,22918,116,1.12 [0.72-1.75],0.6189079547198182
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,22878,116,1.02 [0.81-1.29],0.8545021923992097
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,22589,118,1.10 [0.74-1.66],0.6348897184581166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,22941,117,1.96 [1.42-2.72],4.416019860288946e-05
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,22941,117,1.00 [0.73-1.38],0.997173106964831
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,22638,116,1.02 [0.85-1.22],0.8385271890897765
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,22323,116,1.09 [0.87-1.36],0.4449303477676284
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,22868,115,1.05 [0.94-1.18],0.3667154826902845
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,22479,109,1.00 [0.72-1.37],0.9757239364115524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,22918,116,1.02 [0.85-1.21],0.8584068693395881
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,22774,117,1.24 [0.89-1.73],0.2045797214435848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,22446,115,1.00 [0.72-1.37],0.99165536971569
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,22774,117,0.95 [0.63-1.41],0.7861235980225025
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,22734,116,1.10 [0.90-1.33],0.3563882135269508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,22918,116,1.06 [0.75-1.49],0.7330558556448198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,22628,113,0.94 [0.77-1.13],0.5015305426076497
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,22670,116,1.19 [0.90-1.58],0.2280678371325565
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,22553,113,1.28 [0.98-1.68],0.0668803209747012
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,22628,113,1.06 [0.80-1.42],0.6756174081415061
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,22706,117,0.99 [0.78-1.25],0.9161023366765172
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,22734,118,1.06 [0.90-1.24],0.5120574705796908
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,22628,113,0.94 [0.70-1.26],0.6659218646606253
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,22835,114,0.86 [0.65-1.12],0.2563845238978757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,22523,112,1.17 [0.93-1.46],0.1717224030047825
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,22661,116,0.99 [0.74-1.32],0.9359906123383696
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,22908,117,0.97 [0.59-1.58],0.8964774908174723
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,22868,114,0.90 [0.59-1.36],0.6098595415882779
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,22679,117,0.99 [0.65-1.50],0.9517574820297376
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,19353,94,1.09 [0.64-1.86],0.7516817610780671
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,19188,99,1.14 [0.96-1.35],0.1389746437204348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,22514,109,0.86 [0.60-1.23],0.4163627237730779
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,22152,109,0.93 [0.63-1.37],0.6998281229794858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,19632,95,1.07 [0.68-1.68],0.7732751283659629
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,22679,117,0.64 [0.39-1.04],0.0712582993249637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,22171,117,1.76 [1.24-2.52],0.0017464269347794
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,22918,116,1.07 [0.75-1.52],0.7054455317305901
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,22734,118,1.01 [0.69-1.48],0.9564236983935436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,22679,117,1.33 [0.87-2.02],0.1908356839292707
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,19186,95,1.12 [0.67-1.89],0.657494232020299
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,22649,116,0.98 [0.87-1.11],0.7789301651755435
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,22740,117,0.49 [0.25-0.95],0.0341129958371058
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,19133,94,1.20 [0.79-1.82],0.390618496788691
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,22628,113,0.69 [0.36-1.33],0.271613324167781
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,22560,113,0.90 [0.55-1.46],0.6618228317417127
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,22168,109,1.05 [0.68-1.64],0.8174284417165789
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,22717,116,1.28 [0.84-1.94],0.2441816608000122
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,22918,116,1.01 [0.67-1.52],0.9619951059619768
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,19188,99,1.03 [0.65-1.63],0.900509265886779
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,22918,116,0.55 [0.30-1.01],0.0521069429740585
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,19730,98,1.20 [0.74-1.94],0.4624865054167862
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,22740,117,1.17 [0.78-1.75],0.4476118770821509
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,22514,109,1.34 [0.84-2.15],0.2196256590422788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,22663,115,1.27 [0.79-2.04],0.323221767152391
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,22152,109,0.93 [0.58-1.49],0.7713247207551143
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,22670,116,0.96 [0.74-1.23],0.7231049561697872
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,19322,96,1.26 [0.65-2.44],0.4892992015698468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,22868,115,1.33 [0.82-2.14],0.2432428773954421
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,22789,114,1.20 [0.80-1.80],0.3855612497149269
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,22868,114,1.13 [0.84-1.51],0.4226111306835588
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,22679,117,1.43 [0.93-2.21],0.1020485741006402
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,22564,113,1.29 [0.75-2.24],0.3609776810556567
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,22740,117,0.92 [0.76-1.12],0.4104801535291162
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,22785,114,1.30 [0.65-2.59],0.4580681677292149
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,19188,99,1.61 [1.07-2.42],0.0220171135433327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,22564,113,1.76 [1.05-2.97],0.0322805409961634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,19124,93,0.88 [0.46-1.67],0.6902177887123188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,19353,94,1.08 [0.65-1.81],0.7625864052981833
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,19188,99,0.85 [0.66-1.11],0.2350262775167264
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,22586,113,1.26 [0.79-2.02],0.3362442817618951
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,22666,116,1.03 [0.74-1.44],0.8586798499069006
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,22918,116,0.99 [0.80-1.23],0.9442564590633576
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,22508,118,0.92 [0.51-1.65],0.7712216020639135
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,22734,116,0.74 [0.42-1.30],0.2961282963642598
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,22835,114,1.07 [0.64-1.77],0.8069497380366456
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,21861,116,0.91 [0.47-1.75],0.7822945507076382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,22629,115,0.89 [0.35-2.27],0.8122290456952983
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,21829,110,1.64 [0.83-3.21],0.1516174587574827
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,19647,99,0.91 [0.60-1.39],0.6636364961809231
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,22878,116,0.91 [0.67-1.23],0.5240386618282726
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,22479,109,0.94 [0.68-1.29],0.6858879991272817
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,22573,116,0.98 [0.81-1.18],0.8042031329013074
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,19149,99,1.16 [0.75-1.80],0.5112682944689482
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,22628,113,1.16 [0.78-1.73],0.4668978857477989
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,19322,96,1.35 [0.85-2.15],0.1970659816943052
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,22868,115,1.23 [0.77-1.96],0.3903178052597568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,22918,116,1.28 [0.89-1.85],0.183771237410585
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,19732,96,1.57 [0.90-2.76],0.114211386335229
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,19353,94,1.63 [1.22-2.17],0.0008836299721033
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,22628,113,1.13 [0.69-1.85],0.6207613626066226
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,22628,113,0.66 [0.39-1.13],0.1319575475711228
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,19632,95,0.69 [0.35-1.38],0.2956619445189236
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,22868,115,1.01 [0.73-1.42],0.9315145771877013
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,21783,113,1.05 [0.61-1.81],0.8525486819641652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,22679,117,0.94 [0.40-2.20],0.8776693126631996
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,22679,117,0.82 [0.41-1.67],0.5924894882106082
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,19691,96,0.85 [0.55-1.30],0.4552326827013923
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,19693,96,1.60 [0.91-2.83],0.1025134646091841
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,19040,95,1.16 [0.90-1.50],0.2595710568885649
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,19040,95,1.09 [0.71-1.68],0.6977389680153978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,19603,94,0.94 [0.70-1.25],0.6484498312007712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,22152,109,0.89 [0.66-1.19],0.4140967154450822
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,22740,117,0.96 [0.79-1.16],0.6558769977181202
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,19632,95,0.89 [0.73-1.08],0.2474108698722421
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,22514,109,1.25 [0.90-1.74],0.1852501577254959
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,21887,117,0.99 [0.65-1.52],0.9755658745410172
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,22819,114,1.31 [0.96-1.80],0.0893483708539937
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,22670,116,0.98 [0.77-1.26],0.8987950542203583
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,22670,116,1.17 [0.73-1.87],0.5162940273312366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,19353,94,0.95 [0.48-1.87],0.8837202168272571
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,19693,96,1.00 [0.48-2.09],0.9970738803143724
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,22868,115,1.48 [0.97-2.26],0.070462419416118
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,19124,93,0.98 [0.65-1.48],0.929207332650621
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,22941,117,1.31 [0.77-2.23],0.3133196173997192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,22670,116,1.08 [0.70-1.66],0.7379452509125946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,22105,111,0.82 [0.54-1.25],0.3543927639567282
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,22564,113,1.14 [0.91-1.42],0.247304358960112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,22670,116,0.73 [0.49-1.09],0.1260238199055997
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,19040,95,0.97 [0.57-1.65],0.909668850601885
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,19702,96,0.93 [0.66-1.31],0.6738297464274481
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,19124,93,0.81 [0.53-1.25],0.3438032758916696
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,22564,113,1.07 [0.91-1.25],0.4141942675332609
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,22564,113,0.99 [0.83-1.17],0.868633060121421
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,22564,113,0.89 [0.53-1.51],0.6710755004549331
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,22706,116,1.02 [0.55-1.92],0.9424924878950356
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,22837,115,1.16 [0.79-1.69],0.4583881068339951
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,22701,116,0.60 [0.28-1.30],0.1951910824880255
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,19632,95,0.99 [0.77-1.27],0.9386750103192808
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,19353,94,0.95 [0.70-1.29],0.7557681880071436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,19632,95,1.11 [0.68-1.81],0.6782488362607089
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19353,94,1.25 [0.86-1.80],0.2425852962290428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,22628,113,1.03 [0.85-1.25],0.7645978767161995
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,22152,109,0.85 [0.58-1.24],0.3942022613539787
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,21849,108,1.14 [0.89-1.47],0.3059027256130632
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,19730,98,1.11 [0.68-1.80],0.6755411059171612
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,22266,114,1.05 [0.75-1.46],0.7955971985898755
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,19188,99,1.57 [1.20-2.06],0.0010513866858416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,22266,114,0.90 [0.58-1.42],0.6575316225891199
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,19730,98,1.03 [0.74-1.43],0.8528882192790205
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,22903,117,0.92 [0.69-1.23],0.5762979361819756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,19322,96,1.28 [0.65-2.53],0.4781419461117061
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,19188,99,1.04 [0.59-1.82],0.8901029427496397
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,19124,93,1.01 [0.72-1.41],0.9591665455373216
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,19353,94,0.76 [0.52-1.12],0.163981670726334
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,19353,94,1.00 [0.76-1.31],0.9880526768464198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,19133,94,1.41 [1.01-1.96],0.0446779372352707
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,19040,95,1.11 [0.72-1.73],0.628506929796258
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,22241,113,0.77 [0.55-1.08],0.1326959766775702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,19233,94,0.78 [0.59-1.03],0.0755039307892392
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,22152,109,1.09 [0.87-1.37],0.4626363461349192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,19353,94,0.92 [0.62-1.37],0.6960063657615075
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,19040,95,0.98 [0.58-1.65],0.9454396931699576
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,22089,113,1.01 [0.79-1.29],0.9487998394142982
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,22152,109,1.01 [0.77-1.32],0.9537778117278252
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,22105,111,0.87 [0.66-1.15],0.3379320823974728
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,22714,115,1.07 [0.87-1.32],0.5206608614661721
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,22564,113,0.73 [0.53-1.02],0.0638560318800065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,22564,113,0.99 [0.78-1.25],0.9300725249428188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,22105,111,0.98 [0.76-1.27],0.9019372087396952
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,19632,95,0.89 [0.69-1.16],0.3938293832458311
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,19387,97,0.52 [0.29-0.95],0.0331854376642922
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,22152,109,1.05 [0.72-1.53],0.7991530803271156
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,19764,99,1.55 [0.62-3.85],0.3452561652401454
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,18596,94,0.90 [0.38-2.16],0.8159457277721172
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,19621,98,1.09 [0.77-1.54],0.6280245719825253
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,19733,99,1.17 [0.89-1.54],0.2520559001374969
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,19473,99,1.17 [0.73-1.89],0.5061289186869637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,19764,99,1.05 [0.40-2.75],0.918672444343092
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFP,Properdin,19764,99,0.44 [0.17-1.14],0.0924729343415844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,22679,117,0.99 [0.79-1.23],0.9258672066888076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,19739,99,1.13 [0.75-1.72],0.5582774944946678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,19186,95,1.39 [0.98-1.98],0.0641638664597813
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,22670,116,1.47 [1.01-2.16],0.0466808673413817
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,22152,109,0.91 [0.69-1.21],0.5367923688616094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,19322,96,0.94 [0.66-1.35],0.7515496800168979
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19693,96,1.24 [0.77-2.01],0.3737858044998766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,19627,96,1.73 [1.12-2.68],0.0144312878091926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,22266,114,0.73 [0.44-1.21],0.2228997548127457
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,19730,98,1.09 [0.90-1.32],0.3961447740204887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,22776,114,1.17 [0.78-1.78],0.4467129119322075
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,22146,118,1.20 [0.98-1.46],0.0775174682343304
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,22760,115,1.03 [0.91-1.15],0.6748370683344193
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,22696,117,0.47 [0.27-0.83],0.0090005849475797
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,19186,95,0.94 [0.67-1.30],0.7017989178019728
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,22514,109,0.90 [0.73-1.11],0.3274976589323712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,19732,96,0.83 [0.59-1.19],0.3175261861931802
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,19124,93,0.88 [0.65-1.18],0.3823590229183929
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,22734,116,1.11 [0.64-1.90],0.7155080601553739
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,22670,116,1.02 [0.75-1.40],0.8961827615483426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,19186,95,0.69 [0.37-1.27],0.2335770604850382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,22740,117,0.84 [0.65-1.08],0.1706118913965845
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,19730,98,1.23 [0.84-1.78],0.2843984250009279
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,19353,94,1.07 [0.70-1.62],0.7562303088933415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,19632,95,0.97 [0.79-1.19],0.7357893864824321
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,19186,95,0.81 [0.51-1.28],0.3711150084357723
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,22810,116,1.42 [0.79-2.56],0.2422354030540291
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,19730,98,0.99 [0.72-1.37],0.9514444585474062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",22589,115,1.03 [0.82-1.31],0.7794457697581586
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,19040,95,1.03 [0.78-1.34],0.8533759589720087
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,22635,116,0.85 [0.65-1.11],0.2357925043152705
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,22514,109,1.39 [0.86-2.24],0.1765898645991962
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,22630,116,0.91 [0.65-1.28],0.5851006360400449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,19188,99,2.70 [1.42-5.12],0.0023418370414953
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,22679,117,1.68 [1.03-2.76],0.0386173283952192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,22266,114,1.67 [1.03-2.73],0.0386728298094611
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,22868,115,1.00 [0.84-1.18],0.9965148082599948
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,19186,95,0.88 [0.57-1.36],0.5705122365032358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,19289,97,0.73 [0.29-1.85],0.503686876520248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,22628,113,0.84 [0.52-1.36],0.4862794068707833
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,22628,113,1.16 [0.81-1.65],0.4291024668486257
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,22628,113,0.96 [0.73-1.26],0.7527387665726332
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,22628,113,1.31 [0.79-2.17],0.2949691526708288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,19691,98,0.94 [0.63-1.40],0.7513919867766471
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,22603,116,0.85 [0.48-1.53],0.5954433701315891
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,22152,109,1.23 [0.86-1.76],0.2475737785465342
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,22918,116,1.15 [0.84-1.58],0.3697928789470552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,19186,95,1.03 [0.67-1.60],0.8865979596795122
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,19186,95,0.63 [0.31-1.28],0.2055132129953591
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,19040,95,1.25 [0.92-1.71],0.1580699948353219
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,22628,113,1.04 [0.90-1.21],0.5891045391072609
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,22868,114,0.98 [0.43-2.26],0.969852688545934
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,19186,95,0.68 [0.36-1.28],0.2295453725299596
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",22465,108,0.97 [0.81-1.16],0.735184401765578
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,22644,117,1.01 [0.80-1.29],0.9042047568538772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,22056,110,1.00 [0.60-1.65],0.9850866274378112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,22105,111,1.04 [0.76-1.42],0.8078838248536782
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,22918,116,1.22 [0.82-1.81],0.3384347776985303
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,19693,96,1.08 [0.58-2.03],0.8071894224322476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,22266,114,0.90 [0.63-1.29],0.5697508847489283
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,19764,99,1.17 [0.72-1.92],0.5285512950425548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,22638,115,1.20 [0.83-1.72],0.3262373197428485
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,19732,96,0.91 [0.73-1.13],0.3770391967530033
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,19627,96,0.95 [0.75-1.20],0.6687649816259009
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,22734,118,0.77 [0.55-1.08],0.1274152921291325
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,19124,93,0.82 [0.53-1.26],0.3688754890989265
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",19196,94,0.84 [0.65-1.08],0.1736094128802393
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,22266,114,0.98 [0.75-1.29],0.8946734634980168
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,22564,113,0.96 [0.77-1.20],0.7026581267234921
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNST,Consortin,22670,116,0.99 [0.85-1.15],0.9250315691657538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,19124,93,1.01 [0.57-1.81],0.9693629552163772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,22941,117,0.56 [0.32-1.00],0.0516798926380644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,22868,114,1.06 [0.74-1.53],0.7434314771109659
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,22679,117,1.22 [0.75-1.98],0.4176098056771057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,22679,117,0.92 [0.46-1.83],0.810119879684387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,22718,113,0.81 [0.51-1.26],0.3466292594278845
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,22628,113,1.05 [0.69-1.59],0.8300752336106063
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,19186,95,1.05 [0.88-1.26],0.5802028552436598
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,19732,96,1.27 [0.85-1.90],0.2416376842130982
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,19730,98,1.31 [0.64-2.69],0.4618858114894347
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,22764,116,1.80 [0.89-3.64],0.1022555189740697
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,22941,117,1.01 [0.55-1.87],0.96798518080508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,19632,95,1.04 [0.72-1.50],0.8342926943927814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,19186,95,0.83 [0.62-1.11],0.207806011511721
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,19233,94,0.96 [0.75-1.23],0.7572305618186252
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,19730,98,2.76 [1.41-5.42],0.0031394263684147
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,22670,116,1.60 [1.07-2.40],0.0220627272118309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,19322,94,1.20 [0.81-1.78],0.3701698707186804
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,19322,96,1.95 [1.29-2.96],0.0016977283805635
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,22941,117,1.58 [1.01-2.46],0.0432315731092177
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,22628,113,1.12 [0.81-1.56],0.4845498329834914
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,19353,94,1.29 [0.93-1.78],0.1241085982502086
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,22663,115,1.98 [1.06-3.68],0.0310078960156334
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,19233,94,0.83 [0.59-1.15],0.2563622392941062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,19627,96,0.87 [0.52-1.46],0.6089688220650338
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,22405,116,0.61 [0.38-1.00],0.0521951709202731
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,22029,112,1.03 [0.85-1.26],0.7655854945523928
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',19133,94,1.39 [0.92-2.11],0.1143088813402862
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,22105,111,0.87 [0.58-1.31],0.5079988458551438
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",19233,94,0.88 [0.55-1.41],0.5922231638129996
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,22181,111,1.00 [0.83-1.20],0.967564057854812
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,19124,93,0.91 [0.51-1.61],0.7374527736751484
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",22564,113,0.97 [0.76-1.23],0.7916206411324055
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,19732,96,1.08 [0.59-1.97],0.7994447552695342
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,22941,117,1.05 [0.80-1.39],0.7200379159340777
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,22781,114,1.14 [0.89-1.47],0.2860820420649516
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,18932,96,1.19 [0.75-1.88],0.4694102272329143
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,22941,117,1.11 [0.84-1.47],0.4627939374831458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,19720,99,1.64 [0.71-3.80],0.2462099571868819
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,22706,114,0.69 [0.47-1.00],0.0528320021164044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,19040,95,1.34 [0.85-2.11],0.2015371335157924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,22760,114,1.15 [0.71-1.87],0.5717596107646635
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",19188,99,1.97 [1.16-3.34],0.0123272288585141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,22868,115,1.10 [0.86-1.41],0.4289174794417506
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,19688,98,1.13 [0.64-1.99],0.6805951484890667
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,19133,94,1.39 [0.92-2.11],0.1210385211727868
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,22840,114,1.05 [0.70-1.58],0.8114441174029904
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,22740,117,1.12 [0.89-1.41],0.3198720578832729
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,19732,96,1.95 [1.11-3.45],0.0205020633085898
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,19658,99,0.91 [0.53-1.56],0.7381372888763889
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,22734,118,0.77 [0.54-1.09],0.1438636913425904
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,22152,109,0.92 [0.75-1.13],0.4481811126166356
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,22465,108,0.94 [0.75-1.17],0.5814262366761513
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,19040,95,1.22 [0.92-1.64],0.170280746124091
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,19040,95,1.40 [0.70-2.78],0.3384023090318216
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,22372,116,0.79 [0.49-1.26],0.3186399638134237
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,19322,96,1.22 [0.73-2.06],0.4446162153147166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,22734,116,1.03 [0.75-1.42],0.8524650166257168
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,22110,108,0.90 [0.73-1.10],0.2941093559251079
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,22663,115,1.17 [0.65-2.12],0.6006696621691505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,22266,114,1.01 [0.77-1.31],0.9493107431487852
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,22774,117,1.32 [0.59-2.96],0.4954196053227643
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,22514,109,1.26 [0.82-1.94],0.2986184662863644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,22868,114,0.90 [0.70-1.16],0.4231099416940218
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,19557,97,0.42 [0.22-0.78],0.0066650983616645
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,22700,116,1.00 [0.86-1.17],0.9575615988521547
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,22774,117,0.86 [0.45-1.64],0.6483673227527704
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,22022,109,1.11 [0.87-1.43],0.4009498928766397
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,22941,117,0.70 [0.41-1.19],0.1885300220916621
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,22514,109,1.05 [0.75-1.48],0.7644276822565392
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,19186,95,0.99 [0.66-1.49],0.9720865764099296
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,22266,114,1.12 [0.98-1.27],0.0888331572436586
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,19732,96,0.96 [0.71-1.31],0.8100458990930934
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,19693,96,0.65 [0.42-1.01],0.0532911097723411
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,19693,96,1.03 [0.84-1.27],0.7512144986598487
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,19124,93,1.08 [0.86-1.37],0.4955355198682049
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,19233,94,0.89 [0.72-1.10],0.2823787222911832
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,19133,94,1.03 [0.87-1.21],0.742429393354707
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,22774,117,1.56 [0.87-2.79],0.1364681201004463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,19739,99,1.01 [0.61-1.65],0.9803128907501116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,19133,94,1.80 [1.14-2.83],0.0109782935460848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22514,109,1.01 [0.77-1.33],0.9357011508535156
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,19188,99,1.17 [0.75-1.83],0.4995441215159131
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,22241,113,1.04 [0.73-1.46],0.839829819301056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,19188,99,1.31 [0.72-2.40],0.3733811685928638
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,19739,99,1.08 [0.59-1.99],0.7934212225596575
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,19188,99,1.07 [0.79-1.44],0.6684984244662351
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,19702,96,0.82 [0.53-1.27],0.3710298979428178
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,19730,98,1.13 [0.63-2.05],0.6810523035750926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,19124,93,0.87 [0.57-1.34],0.5325000774847237
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,19133,94,1.17 [0.98-1.40],0.0748895554661464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,17120,83,1.07 [0.87-1.32],0.5390160142893072
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,22701,118,1.64 [0.94-2.85],0.0814701133622939
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,22282,108,0.90 [0.66-1.24],0.5305588316832164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,22093,113,1.10 [0.78-1.57],0.5815833903297759
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,22706,117,1.03 [0.87-1.22],0.717369309598691
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,22355,113,1.28 [0.87-1.89],0.2085345850174361
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,19310,94,1.30 [0.93-1.83],0.1263599060894779
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,19444,98,0.88 [0.43-1.79],0.7195007579427106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,22266,114,0.98 [0.80-1.19],0.8242892145274802
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,19730,98,1.38 [0.72-2.65],0.3270807027545312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,19730,98,1.18 [0.63-2.21],0.6139559967975234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,19124,93,1.17 [0.75-1.84],0.4935640129643719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,22679,117,1.22 [0.90-1.64],0.2015264915423548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,22672,115,1.01 [0.77-1.31],0.9607640335801731
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,19693,96,1.15 [0.86-1.54],0.3392255661388137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,22687,115,0.92 [0.68-1.25],0.5987290897871496
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,22630,117,1.22 [0.84-1.76],0.2962007084961874
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,21149,115,1.19 [0.80-1.76],0.3911714298824894
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,19322,96,1.04 [0.71-1.53],0.8478858949411456
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,22740,117,1.02 [0.68-1.54],0.9179710239010748
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,22204,114,1.13 [0.90-1.42],0.2887922206852467
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,22670,116,1.49 [0.77-2.87],0.2337017245648557
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,22918,116,1.83 [1.10-3.05],0.0192715395727369
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,17801,91,1.33 [0.57-3.07],0.5097670017209015
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,22809,114,0.73 [0.49-1.10],0.131413911307516
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,22655,118,1.13 [0.67-1.91],0.6370402140165718
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,19186,95,1.11 [0.66-1.86],0.6898300463310387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,19513,94,0.83 [0.56-1.21],0.3337721369195742
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,22514,109,1.53 [0.95-2.47],0.0783551004750679
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,22628,113,1.07 [0.79-1.45],0.6672815294464071
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,22631,117,1.06 [0.90-1.25],0.4519251578114087
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,22774,117,1.10 [0.87-1.39],0.4204279198995734
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,22868,115,0.93 [0.75-1.15],0.5076761132142665
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,22241,113,0.85 [0.56-1.29],0.4461539405081306
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,22868,115,1.14 [0.90-1.44],0.2665742968242594
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,22241,113,1.13 [0.89-1.45],0.3175968678795455
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,22902,117,1.22 [0.61-2.45],0.5743954692307923
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,22918,116,1.20 [0.82-1.76],0.3454882110495835
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,22666,116,1.03 [0.87-1.23],0.722789092107716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,22597,116,1.02 [0.89-1.18],0.766649093516415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,22918,116,1.08 [0.88-1.33],0.4483965783569971
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,22491,112,1.02 [0.80-1.29],0.874159621007635
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,22774,117,1.11 [0.88-1.41],0.3639027561524552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,19040,95,1.03 [0.79-1.34],0.8437267184430863
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,19390,95,1.05 [0.74-1.50],0.7668080220473277
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",19133,94,0.91 [0.70-1.17],0.4496345664520441
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,19040,95,1.05 [0.81-1.36],0.7037076285365786
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,19730,98,0.73 [0.33-1.65],0.4539869324491196
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,19322,96,1.00 [0.79-1.27],0.9727174351582912
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,22868,114,0.96 [0.83-1.12],0.6331329123544134
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,22774,117,1.05 [0.74-1.49],0.7819741974525375
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,19188,99,0.96 [0.66-1.39],0.8219193449317334
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,19188,99,1.16 [0.85-1.59],0.3507423672039204
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,22628,113,0.98 [0.85-1.12],0.7476282897008244
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",22465,108,0.88 [0.70-1.11],0.2769661867793048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,19698,99,1.00 [0.84-1.20],0.9945358950211236
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,22578,115,1.04 [0.84-1.28],0.7154396366548206
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,19188,99,1.20 [0.83-1.72],0.3301399171588958
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,22774,117,1.00 [0.84-1.19],0.990853120339684
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",22740,117,0.73 [0.46-1.16],0.1810984785168199
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,19186,95,0.81 [0.32-2.06],0.6579361275126296
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,19040,95,1.07 [0.80-1.43],0.6533264794653413
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,19040,95,1.60 [0.93-2.75],0.0906354947870069
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCN,Decorin,22266,114,1.35 [0.66-2.75],0.4073177551544037
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,19322,96,1.06 [0.86-1.30],0.6131163341513206
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,22868,114,0.86 [0.67-1.11],0.2523365804863001
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,22564,113,0.96 [0.80-1.15],0.6408169656952059
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,22105,111,1.01 [0.79-1.28],0.9561466344902192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,22670,116,1.17 [0.68-2.00],0.5757794757416476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,19124,93,0.83 [0.60-1.13],0.2305362902698268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,19040,95,0.85 [0.65-1.12],0.250660402304238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,22740,117,0.81 [0.58-1.12],0.1952263235735268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,19133,94,1.43 [1.01-2.01],0.0422982405715932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",22564,113,1.06 [0.73-1.54],0.7461739145214317
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,22636,116,0.91 [0.65-1.28],0.5809350614925923
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,19702,96,0.87 [0.64-1.17],0.3549129125124077
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,19322,96,0.99 [0.77-1.26],0.9171523217223818
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,22868,115,1.98 [0.99-3.97],0.054034462960516
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,19730,98,0.91 [0.57-1.46],0.6970522484768837
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,19632,95,0.91 [0.61-1.37],0.6562979314782873
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,19186,95,0.80 [0.45-1.43],0.4556263709156095
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,19188,99,1.25 [0.57-2.74],0.5789994149435611
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,19188,99,0.98 [0.69-1.41],0.9328904572162144
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,19186,95,1.15 [0.67-1.98],0.6066748055622578
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,22152,109,1.21 [0.93-1.57],0.1539732660682023
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",22628,113,1.02 [0.86-1.21],0.8392884777967593
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,22190,115,1.05 [0.78-1.42],0.7513419764054673
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,19036,99,1.24 [0.88-1.76],0.2220239257559015
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,19124,93,0.84 [0.56-1.25],0.3976102306471436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,19124,93,0.88 [0.66-1.18],0.3936491314569662
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,19124,93,1.02 [0.73-1.42],0.8999881348122094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,22358,112,1.05 [0.94-1.17],0.3861402583695936
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,19133,94,1.12 [0.80-1.56],0.5112460732916676
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,19188,99,1.05 [0.75-1.46],0.7791107135274776
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,22918,116,0.92 [0.72-1.17],0.5047673976666505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,19124,93,0.63 [0.36-1.12],0.1192207357918821
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,19188,99,1.15 [0.81-1.63],0.4240646133567319
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,22241,113,1.02 [0.63-1.65],0.9424149041222344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,19133,94,0.89 [0.58-1.38],0.6163939669833509
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,19627,96,1.01 [0.63-1.62],0.9723029791985944
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,19693,96,1.24 [0.86-1.80],0.2527418636910554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",22603,116,0.98 [0.85-1.14],0.8289256990331639
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,19186,95,1.12 [0.72-1.73],0.6169022236148967
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,19322,96,1.02 [0.48-2.14],0.9670379012633862
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,22868,115,1.03 [0.78-1.36],0.8458773891829023
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,22941,117,1.22 [0.70-2.11],0.4785817321389943
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,22482,108,1.14 [0.79-1.64],0.4947957549178413
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,22564,113,1.01 [0.84-1.22],0.9141613266097924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,19693,96,0.93 [0.70-1.24],0.624775437651268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,19702,96,1.10 [0.80-1.52],0.5420313559871802
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,22941,117,1.17 [0.86-1.59],0.3226008761877965
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,22740,117,0.83 [0.47-1.46],0.5219076860255665
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,19233,94,1.08 [0.89-1.30],0.4346450161773934
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,19233,94,1.03 [0.70-1.51],0.8927297545754416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,19233,94,0.92 [0.68-1.24],0.5803385674726372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,19040,95,0.86 [0.54-1.35],0.505771334625561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,22850,116,0.94 [0.77-1.15],0.5391065899871503
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,19693,96,0.87 [0.66-1.15],0.3296484358152093
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,22564,113,0.94 [0.78-1.14],0.5228114858729029
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,19632,95,1.00 [0.74-1.36],0.998236709014421
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,19322,96,0.96 [0.67-1.38],0.8431958579701284
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,19131,96,1.03 [0.82-1.30],0.7834432334922075
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,22266,114,1.09 [0.84-1.41],0.5199100146027331
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,19693,96,0.79 [0.47-1.35],0.3977055934618289
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,19233,94,0.88 [0.69-1.13],0.3176536071658777
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,19632,95,0.95 [0.74-1.23],0.7132846670465984
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,22631,115,1.13 [0.58-2.21],0.7260967503041154
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,19124,93,0.97 [0.78-1.20],0.7568606830211984
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,19632,95,0.97 [0.82-1.15],0.7379078720558938
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,19702,96,0.90 [0.62-1.30],0.5801763203234815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,22514,109,0.92 [0.69-1.22],0.5570732851005477
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,19693,96,1.19 [0.85-1.67],0.315148897363167
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,22740,117,0.95 [0.69-1.29],0.729811279332451
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,19186,95,0.99 [0.57-1.74],0.9849407905952932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,19124,93,1.02 [0.87-1.19],0.8325333018409056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,19693,96,0.98 [0.85-1.13],0.7748909911020245
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,22670,116,1.00 [0.87-1.15],0.9910833167264766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,22465,108,1.38 [0.98-1.96],0.0674458659727814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,22564,113,0.56 [0.31-1.02],0.0577782419284016
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,22628,113,1.45 [0.93-2.27],0.1050215231233317
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,22226,118,0.81 [0.46-1.42],0.4549477526069311
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,22564,113,0.91 [0.55-1.51],0.7257083366423012
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,22482,116,1.17 [0.88-1.55],0.270486590196712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,22941,117,0.78 [0.42-1.44],0.4280125015376795
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,22795,114,1.03 [0.78-1.36],0.8335151724337595
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,22514,109,0.90 [0.60-1.33],0.588755684786006
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,22564,113,1.01 [0.75-1.36],0.9256267842397018
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,22432,115,1.51 [0.96-2.39],0.0759955581455254
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,19702,96,1.17 [0.67-2.05],0.5694460259031373
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,22679,117,0.79 [0.42-1.45],0.4419852181455367
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,22800,114,1.03 [0.63-1.70],0.897892716445396
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,22484,113,0.99 [0.72-1.38],0.967429179427024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,19322,96,1.05 [0.84-1.32],0.6734287392259932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,19598,95,1.18 [0.74-1.87],0.4950387948472314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,19186,95,0.99 [0.72-1.34],0.9279411711587716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,22564,113,1.10 [0.54-2.22],0.7956341623511276
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,19732,96,0.97 [0.73-1.28],0.8322061543639702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,22266,114,1.21 [1.01-1.46],0.0401239658921975
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,19627,96,0.85 [0.52-1.40],0.5324818799184017
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,19186,95,0.96 [0.71-1.30],0.7847670791937148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,22105,111,1.04 [0.86-1.25],0.6926092716022165
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",19632,95,0.95 [0.78-1.15],0.6042524994979057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,19693,96,0.96 [0.63-1.48],0.8694890216018876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,19627,96,1.29 [0.93-1.78],0.1218831145633117
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,19186,95,0.92 [0.72-1.19],0.5349527697004913
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,19627,96,1.09 [0.70-1.70],0.7104110364571679
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,22514,109,0.97 [0.81-1.16],0.7203057220180408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,22829,114,0.97 [0.56-1.68],0.9109626407861532
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,22105,111,1.00 [0.62-1.62],0.9967801515543622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",19732,96,1.05 [0.81-1.36],0.6924117572091477
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",19233,94,0.96 [0.78-1.18],0.6892843272081748
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,19133,94,1.11 [0.82-1.50],0.5173633912064988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,19200,98,0.97 [0.57-1.65],0.919429674294568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,19124,93,0.86 [0.56-1.33],0.4994336795141884
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,22868,114,1.84 [1.20-2.84],0.00539874165556
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,22628,113,0.77 [0.64-0.93],0.0067970653718494
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,19627,96,1.09 [0.69-1.71],0.7145759476163583
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,19133,94,1.10 [0.66-1.82],0.7261744058056985
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,19702,96,1.01 [0.77-1.33],0.9516760632146491
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,22266,114,1.57 [1.01-2.44],0.0439446300526081
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,19233,94,1.61 [0.82-3.15],0.1668665987282681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,19188,99,1.27 [0.91-1.77],0.166121086583118
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,19732,96,0.93 [0.76-1.16],0.5315982924773164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,19632,95,1.72 [0.98-2.99],0.0566089576250231
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,19353,94,0.88 [0.49-1.57],0.6576839328551605
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,22695,118,0.77 [0.45-1.31],0.3390341880461626
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,19702,96,1.23 [0.73-2.10],0.4366995852873464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,22645,117,1.60 [0.89-2.85],0.1139413756341328
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,22479,109,2.34 [1.39-3.94],0.0013871667593492
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,19186,95,1.15 [0.85-1.55],0.3778210857337361
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,22633,115,1.03 [0.88-1.21],0.6801955591563569
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,22152,109,0.99 [0.66-1.50],0.971687081961278
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,19632,95,1.46 [0.82-2.59],0.1994067497447468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,22941,117,0.41 [0.20-0.82],0.0121239068581609
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,22628,113,1.05 [0.79-1.40],0.7429579382977167
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,19732,96,0.90 [0.69-1.17],0.4219218958634252
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,19233,94,0.91 [0.77-1.07],0.2632785681981592
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",19693,96,0.90 [0.61-1.31],0.5760816036053137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",19564,95,0.97 [0.81-1.16],0.7248546562391667
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,19133,94,1.03 [0.76-1.38],0.8552969623531697
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,19233,94,1.17 [0.75-1.82],0.4922920671913539
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,22514,109,0.89 [0.67-1.19],0.4307199835138998
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,19188,99,1.04 [0.84-1.29],0.7179786117976945
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,22670,116,1.02 [0.79-1.31],0.8980742231165971
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,22918,116,0.98 [0.83-1.16],0.8200761457616791
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,19702,96,0.87 [0.64-1.18],0.3832340325034347
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,19133,94,1.17 [0.79-1.76],0.4337722053396232
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,22241,113,1.04 [0.58-1.87],0.8886225485740419
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,19702,96,0.92 [0.73-1.15],0.4438022899692746
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,19124,93,1.07 [0.85-1.34],0.5598697526040625
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELN,Elastin,19732,96,1.52 [0.89-2.58],0.1257835148578354
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,22564,113,0.74 [0.51-1.07],0.1091105072185165
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,19133,94,0.90 [0.53-1.55],0.7167486579468147
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,22241,113,0.93 [0.65-1.33],0.6922364804477278
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,18226,90,1.13 [0.75-1.69],0.5691309858000932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,22941,117,1.37 [0.52-3.56],0.5239423489747363
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,22634,114,1.03 [0.83-1.27],0.8099372212270961
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,22868,115,0.97 [0.75-1.24],0.788126995158072
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,19233,94,1.01 [0.71-1.44],0.958715507301141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,19627,96,1.06 [0.78-1.45],0.7082690615343407
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,19133,94,0.50 [0.23-1.10],0.0854791023647373
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,19133,94,0.90 [0.56-1.45],0.6582749135076259
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,22941,117,0.74 [0.42-1.32],0.3137814064229695
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,22774,117,0.99 [0.67-1.47],0.9542921960973312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,19233,94,0.91 [0.53-1.56],0.7332355631302123
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,21968,110,1.08 [0.89-1.32],0.4109031568800932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,19627,96,0.91 [0.62-1.33],0.6200200072747863
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,22152,109,1.04 [0.70-1.53],0.8599862690934179
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,22266,114,0.88 [0.40-1.95],0.7549001136285007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,22266,114,1.19 [0.64-2.23],0.5859736672679119
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,19233,94,0.78 [0.53-1.15],0.2051557196160901
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,19188,99,1.31 [0.84-2.04],0.2322067377628477
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,19186,95,0.91 [0.65-1.28],0.5930315189594003
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,22668,116,0.86 [0.73-1.01],0.0660164304510045
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,19627,96,0.82 [0.49-1.38],0.452645368638606
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,22740,117,0.82 [0.51-1.32],0.4177900891408983
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,22105,111,1.07 [0.84-1.35],0.5860496337746728
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,21859,109,1.43 [0.86-2.36],0.1669921240074316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,19322,96,1.19 [0.60-2.37],0.6246652744916721
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,22941,117,1.47 [0.77-2.80],0.2394632877533228
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,22465,108,1.06 [0.61-1.83],0.8478645391575499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,22266,114,0.92 [0.70-1.22],0.5806449677548409
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,19353,94,1.18 [0.79-1.74],0.4187330805214513
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,22628,113,1.17 [0.95-1.43],0.1387853843651843
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,19233,94,0.90 [0.68-1.19],0.4577122864033862
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,22834,114,1.25 [0.72-2.16],0.42671795609918
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,22740,117,0.61 [0.31-1.21],0.1563523629735865
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,22604,116,1.12 [0.47-2.68],0.7950076645858953
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,22740,117,0.52 [0.27-1.02],0.0584856541270184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,22564,113,1.01 [0.86-1.18],0.9498872211248972
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,19186,95,1.06 [0.84-1.35],0.6229240304319794
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,19040,95,1.46 [1.03-2.06],0.0324128326787455
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,22465,108,1.03 [0.83-1.27],0.7850168458198288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,19353,94,0.77 [0.41-1.42],0.3976088481844831
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,19188,99,1.52 [1.00-2.31],0.048412552917355
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,19627,96,0.83 [0.49-1.41],0.4908130302875761
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,19322,96,1.04 [0.88-1.22],0.6806834696523493
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,22523,112,0.80 [0.41-1.55],0.5080574485314215
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,19133,94,1.54 [1.16-2.05],0.0029002155270521
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,22941,117,1.35 [0.81-2.25],0.2547967636554621
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,22663,115,0.69 [0.42-1.12],0.1335700303073595
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,19040,95,0.72 [0.47-1.11],0.1428063724407271
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,19188,99,1.19 [0.89-1.59],0.2406362565984486
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,19693,96,0.90 [0.70-1.15],0.3802773361771049
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,19040,95,1.23 [0.84-1.82],0.2901121065135223
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,19188,99,1.02 [0.82-1.26],0.8668059335897519
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,19353,94,1.43 [0.90-2.27],0.1280906464879243
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,19133,94,0.97 [0.69-1.36],0.846937752132898
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,19133,94,1.14 [0.78-1.66],0.4960334148596276
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,22868,115,0.91 [0.45-1.84],0.7855298379120327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,19739,99,0.68 [0.33-1.38],0.2864595829292033
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,19477,99,0.63 [0.31-1.27],0.1952526529631428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,22679,117,0.93 [0.69-1.25],0.6261521010251072
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,19764,99,1.10 [0.69-1.74],0.6994080720870163
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,19647,99,1.09 [0.51-2.31],0.830286015668805
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,19764,99,1.05 [0.29-3.81],0.9388178651323666
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,22734,116,1.01 [0.76-1.35],0.9199194264703876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,22733,114,0.77 [0.42-1.42],0.4065015515556686
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,22705,118,0.82 [0.48-1.41],0.4702415028323358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,22697,118,1.49 [0.60-3.72],0.3903424669141395
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",22663,115,1.10 [0.93-1.31],0.2621732974188525
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",22670,116,1.06 [0.86-1.31],0.6036723762342378
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",19732,96,1.52 [1.06-2.17],0.0210625663178862
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",22941,117,1.15 [0.83-1.60],0.3861632650994806
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,22800,114,1.02 [0.80-1.29],0.8874569058813254
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,22233,114,0.80 [0.58-1.09],0.1544547877124566
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,22628,113,1.09 [0.81-1.47],0.5726189974016085
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,22670,116,1.03 [0.83-1.27],0.8184330312880379
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,19632,95,0.91 [0.67-1.22],0.5172883779949489
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,19702,96,0.94 [0.83-1.07],0.3735888573382699
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,19627,96,1.51 [0.87-2.62],0.1471713754295938
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,19233,94,0.81 [0.58-1.12],0.1974442264106491
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,19732,96,1.83 [1.02-3.29],0.0419720792439285
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,22564,113,1.37 [0.83-2.25],0.2194077214377363
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,22636,116,1.22 [0.70-2.11],0.4888705175198465
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,19632,95,0.95 [0.75-1.21],0.6809814193528116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,22941,117,0.58 [0.32-1.06],0.0770008887680926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,19186,95,1.07 [0.82-1.41],0.6075048967374733
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,22873,117,0.98 [0.59-1.65],0.9435027145457824
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,22918,116,0.59 [0.39-0.89],0.0127968131077721
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,19730,98,1.50 [0.82-2.76],0.1928023670373807
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,19186,95,1.19 [0.87-1.64],0.2688058402661049
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",22670,116,1.04 [0.83-1.30],0.7216891269470318
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,19732,96,1.07 [0.82-1.40],0.5976691151534361
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,22628,113,0.66 [0.46-0.94],0.0216766669116525
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,19702,96,0.86 [0.39-1.93],0.720734305890834
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,22679,117,1.01 [0.72-1.43],0.9412473841220144
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,22558,118,1.13 [0.84-1.51],0.4240208647860797
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,22152,109,0.86 [0.64-1.16],0.3306376548039285
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,22666,118,0.83 [0.61-1.14],0.2504122000264238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,19698,99,0.83 [0.61-1.12],0.2268919122513436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,22544,117,0.97 [0.65-1.45],0.8903782568139256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,22670,116,1.01 [0.69-1.46],0.9783370741326862
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,22811,116,1.06 [0.75-1.48],0.7548926338121084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,22241,113,1.05 [0.77-1.41],0.7691515392034584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,22679,117,0.84 [0.62-1.13],0.2483918717768828
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,22628,113,0.93 [0.73-1.19],0.5697691834070499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,22152,109,1.14 [0.87-1.48],0.3380415124903754
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",19133,94,0.90 [0.65-1.27],0.5590668362180131
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",19133,94,1.08 [0.78-1.51],0.6339017220168328
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,22152,109,0.94 [0.71-1.24],0.6445312244530668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,22152,109,0.92 [0.63-1.34],0.6703813883963413
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,22697,118,0.77 [0.50-1.19],0.2377436873647229
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,19293,96,0.88 [0.46-1.68],0.6973750897800165
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",19702,96,0.95 [0.74-1.21],0.658038049053836
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,19188,99,1.33 [1.02-1.74],0.0380756649007353
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,19188,99,1.07 [0.73-1.56],0.7428896930176421
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,22774,117,1.07 [0.86-1.32],0.5517249272454758
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,22628,113,1.13 [0.88-1.44],0.3330790759885317
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,19188,99,1.29 [0.93-1.78],0.1243887916052188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,22829,114,1.07 [0.93-1.23],0.3526174115029925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,22836,114,1.24 [0.97-1.59],0.0790123364504672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,19188,99,1.20 [0.70-2.05],0.515284978537669
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,22241,113,1.27 [0.77-2.09],0.3482146993415801
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,19188,99,1.21 [0.85-1.74],0.2869542259665446
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,19040,95,1.02 [0.80-1.30],0.8640811817946644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,19002,95,1.18 [0.72-1.91],0.5083282196179881
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,22740,117,0.50 [0.30-0.82],0.0065989064955699
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,19730,98,0.77 [0.52-1.14],0.1886440013787951
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,19693,96,1.12 [0.66-1.91],0.6677642402545038
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,22740,117,1.20 [0.57-2.56],0.6324133117872428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,19322,96,1.44 [1.00-2.07],0.0509118175019452
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,19739,99,1.10 [0.82-1.49],0.5153111053194313
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,22105,111,0.94 [0.70-1.28],0.70642696892887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",19124,93,0.92 [0.72-1.19],0.5319693787688322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,19133,94,0.99 [0.65-1.49],0.9462848835688802
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,22105,111,0.92 [0.73-1.15],0.4632207633568688
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,22672,117,0.98 [0.79-1.21],0.8659659245463552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,19702,96,1.02 [0.84-1.24],0.8594941404145028
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,22737,116,0.94 [0.81-1.09],0.3941330006557649
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,22514,109,1.08 [0.74-1.58],0.6835654371398883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,22514,109,0.98 [0.82-1.17],0.8069854922555506
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,22056,110,1.00 [0.69-1.44],0.987436115253634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,19632,95,0.80 [0.57-1.12],0.1910108074304606
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,22152,109,0.97 [0.83-1.13],0.6909304071882499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22514,109,1.69 [0.94-3.04],0.0801722861688298
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,22524,113,0.52 [0.22-1.19],0.1209826332638442
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,22152,109,0.65 [0.36-1.18],0.1597357379894101
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,22918,116,2.34 [1.42-3.83],0.0007838508721006
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,22740,117,0.74 [0.46-1.19],0.2108094697038613
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,22105,111,0.96 [0.73-1.26],0.7543120431471673
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,22152,109,1.01 [0.62-1.65],0.971245781540577
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,19764,99,1.02 [0.49-2.11],0.960633776273746
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,19693,96,1.05 [0.68-1.61],0.8340042234381099
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,19627,96,0.92 [0.52-1.63],0.7724887057211479
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,19188,99,1.14 [0.99-1.32],0.0752225249684957
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,22633,117,0.81 [0.45-1.46],0.4800597924860744
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,22868,115,1.61 [0.93-2.80],0.0896212399559928
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,22666,116,1.03 [0.95-1.12],0.4862550647296013
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,19002,95,1.85 [1.18-2.91],0.0074045648566768
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,22105,111,1.14 [0.78-1.67],0.4863409770346139
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,19188,99,1.00 [0.65-1.56],0.9838449755436554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,22628,113,0.98 [0.81-1.20],0.8656568975474805
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,22152,109,1.04 [0.87-1.24],0.6772269193737956
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,19133,94,0.88 [0.65-1.18],0.3874152234861653
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,19186,95,0.79 [0.44-1.43],0.4322307649496517
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,22439,109,0.71 [0.37-1.34],0.2867812763386232
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,19233,94,1.21 [0.90-1.62],0.2147334365341036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FST,Follistatin,22734,116,1.00 [0.72-1.38],0.9892926010990007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,19233,94,1.86 [0.86-4.01],0.1134489842741105
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,22630,115,1.20 [0.71-2.03],0.4953429420492743
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,19664,95,1.06 [0.85-1.34],0.6012105880706557
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,22813,116,1.09 [0.89-1.34],0.4186898530923743
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,19322,96,0.92 [0.67-1.26],0.6147929213389212
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FURIN,Furin,22740,117,0.97 [0.60-1.58],0.901828107869476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,22121,109,0.88 [0.56-1.37],0.5635809834076482
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",19310,94,0.99 [0.73-1.35],0.9693683083771508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,22868,115,1.03 [0.72-1.48],0.8605358990163158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",22514,109,0.94 [0.70-1.26],0.6704348299418692
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",22868,114,0.98 [0.78-1.22],0.8407639104340968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,22241,113,1.03 [0.80-1.33],0.8237283253836799
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,22644,117,0.97 [0.81-1.16],0.7176561439563379
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,19186,95,0.81 [0.55-1.20],0.2967112035128429
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,19124,93,1.27 [0.89-1.81],0.1963054821751452
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,19627,96,1.16 [0.81-1.65],0.4235246159984976
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,19353,94,1.15 [0.89-1.48],0.2836428279674333
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,19124,93,0.83 [0.58-1.18],0.3004104813706858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,19040,95,0.92 [0.43-1.97],0.8249673850974734
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,19188,99,1.02 [0.67-1.54],0.9373889045206216
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,19353,94,1.01 [0.68-1.48],0.9781001960129012
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,19233,94,0.84 [0.57-1.25],0.3885346513164205
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,19040,95,1.22 [0.96-1.55],0.1070061374467184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,22774,117,0.96 [0.74-1.25],0.7490787314187523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22564,113,1.40 [0.77-2.55],0.2669593244537761
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,22868,114,0.84 [0.44-1.59],0.5897931835607149
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,22241,113,1.10 [0.74-1.64],0.622540159750342
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,19732,96,0.95 [0.46-1.97],0.8946106840328021
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,22564,113,1.16 [0.52-2.59],0.7121263388668511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,19133,94,1.15 [0.73-1.80],0.5480560649972113
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,18901,96,0.85 [0.49-1.46],0.5463625698597421
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,19702,96,1.04 [0.51-2.12],0.9143660988786316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,19353,94,1.30 [1.01-1.68],0.0406886018911672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,22793,116,1.03 [0.54-1.97],0.9216789855744568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,19133,94,0.97 [0.61-1.54],0.9056759437210472
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,19693,96,1.15 [1.01-1.30],0.0305885241023706
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,19040,95,1.51 [0.74-3.10],0.2581414765533814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",19233,94,0.97 [0.75-1.26],0.811362358203103
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,19186,95,1.17 [0.82-1.66],0.3824512182586443
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,19656,96,1.09 [0.81-1.47],0.5840820909722657
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,22241,113,1.02 [0.77-1.36],0.8756154942891015
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,22105,111,1.07 [0.76-1.50],0.6930699012583581
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,19133,94,1.34 [0.99-1.82],0.0580493774063076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,19764,99,0.53 [0.25-1.14],0.1034218885523657
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,19693,96,0.93 [0.78-1.12],0.4576114689065256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,22152,109,1.11 [0.97-1.26],0.1451759742204161
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,18853,94,1.11 [0.77-1.62],0.571067176176996
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,19133,94,0.78 [0.49-1.26],0.313118714478624
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",22564,113,1.28 [0.80-2.05],0.3117097210775365
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,22941,117,1.79 [1.38-2.32],9.186503395899445e-06
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,22670,116,0.66 [0.41-1.05],0.0800440196193962
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,22105,111,0.94 [0.60-1.47],0.7925078035969149
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,19732,96,1.07 [0.77-1.49],0.6942190894420074
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,22115,108,1.19 [0.84-1.67],0.3346932032629967
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,22152,109,1.04 [0.80-1.36],0.7526317727417665
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,22152,109,0.96 [0.83-1.11],0.6232207676647589
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,22829,114,1.41 [0.79-2.51],0.2503190585004242
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,22564,113,1.39 [0.65-2.97],0.3891044032424507
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,22448,109,1.35 [0.75-2.42],0.3153747538386985
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,19097,89,0.83 [0.59-1.17],0.2842613573045538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,22105,111,1.24 [1.01-1.53],0.0443376839929277
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,19732,96,0.95 [0.72-1.26],0.7352346080915155
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,19689,96,0.80 [0.53-1.20],0.2807841660861505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,22272,118,1.07 [0.67-1.71],0.7854097205418952
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,22645,117,1.09 [0.78-1.51],0.6237425242498604
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,22514,109,1.58 [0.77-3.27],0.2136870304314326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,22636,116,0.97 [0.88-1.07],0.4949243466062757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,22152,109,0.99 [0.90-1.10],0.8759544672463437
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,19322,96,0.68 [0.34-1.36],0.2749492444688024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,22105,111,1.17 [0.91-1.50],0.2188141740284577
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,22670,116,0.90 [0.73-1.09],0.2783503687040448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,19702,96,1.37 [0.87-2.14],0.1747675826039058
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,19702,96,0.86 [0.66-1.13],0.2822578310238001
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,19322,96,1.21 [0.71-2.06],0.4849855388762855
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,19040,95,1.26 [0.93-1.70],0.1315930570754504
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,19233,94,1.43 [1.04-1.96],0.0264629043055499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,19693,96,0.90 [0.46-1.76],0.760886199399343
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,19632,95,0.94 [0.77-1.15],0.5693057314523124
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,19188,99,1.44 [1.15-1.79],0.001289826937275
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,19188,99,0.98 [0.80-1.19],0.8161139729649164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,19040,95,0.98 [0.72-1.34],0.9038968104418922
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,21677,108,1.09 [0.58-2.05],0.788694663188832
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,19279,96,1.37 [0.82-2.29],0.2268703607049002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,22514,109,0.79 [0.51-1.22],0.2865206757600998
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,19188,99,1.51 [0.97-2.37],0.0710113280782209
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,22266,114,1.19 [0.90-1.56],0.2161629727973855
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,22632,116,0.83 [0.53-1.30],0.4180471054594007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,19124,93,0.86 [0.49-1.51],0.606355470326742
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,22519,115,0.97 [0.73-1.29],0.8236728235486
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",19322,96,1.11 [0.89-1.38],0.3491823658597608
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,22105,111,1.09 [0.79-1.51],0.6081414618173904
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,19627,96,1.19 [0.89-1.59],0.2310102865988385
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,19256,98,1.22 [0.80-1.84],0.3532740104358965
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,19732,96,0.94 [0.71-1.23],0.6380686795096191
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,22918,116,0.89 [0.65-1.22],0.4592490914481565
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,19322,96,1.03 [0.77-1.37],0.841186542879241
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,19702,96,0.89 [0.70-1.13],0.3518148028524342
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,22152,109,0.96 [0.74-1.25],0.7640242926056422
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,19186,95,0.83 [0.53-1.29],0.4025377013512415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,22679,117,0.81 [0.59-1.12],0.1955880660682327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,19233,94,1.47 [0.95-2.28],0.0842974725662961
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,19322,96,1.42 [0.84-2.39],0.1916814873696714
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,19702,96,1.04 [0.81-1.33],0.7809139908599569
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,22868,115,1.20 [0.58-2.49],0.6151784021494446
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,22628,113,1.00 [0.85-1.18],0.977569609214739
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,19632,95,0.85 [0.56-1.31],0.463948267128711
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",19730,98,0.97 [0.60-1.57],0.8932224636068291
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,22544,117,0.79 [0.47-1.33],0.3749541054219879
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,19133,94,0.91 [0.68-1.23],0.5447653725618333
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,21990,112,0.99 [0.82-1.21],0.9565702546681932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,19322,96,1.19 [0.68-2.10],0.5391268250590306
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,22644,117,0.95 [0.79-1.14],0.5674868770970241
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,22564,113,0.85 [0.76-0.96],0.0081662452565673
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,22868,114,0.67 [0.38-1.16],0.1545855483714203
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,22514,109,0.85 [0.63-1.15],0.2804341107085699
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,19627,96,1.36 [0.96-1.93],0.0865261166168523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,19632,95,0.65 [0.38-1.12],0.1220151886816718
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,19739,99,1.20 [0.81-1.77],0.3537155725464478
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,19632,95,0.96 [0.73-1.26],0.7660992574103023
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,22105,111,0.61 [0.30-1.24],0.1737247257771287
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,22054,113,0.93 [0.51-1.69],0.8113703362346744
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,19124,93,0.94 [0.67-1.32],0.7085506504204594
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,19702,96,0.94 [0.54-1.64],0.8302659142342992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,19632,95,1.06 [0.77-1.48],0.7067092785652784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,22266,114,0.92 [0.72-1.18],0.5148993600115505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,19627,96,1.23 [0.91-1.66],0.1771289812023982
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,22670,116,0.99 [0.87-1.13],0.9169391432535552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,19732,96,0.99 [0.73-1.34],0.9341320501135516
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",19702,96,1.26 [0.86-1.86],0.2358464739908563
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",19124,93,1.05 [0.75-1.47],0.7728720967298472
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,22266,114,0.93 [0.66-1.31],0.6701795040881238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,22581,116,1.52 [0.77-3.02],0.2291741517510642
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,19233,94,1.29 [0.90-1.85],0.1700583487263358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",22564,113,1.15 [0.88-1.50],0.2986609126983217
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,18934,95,1.01 [0.79-1.30],0.9223958305516968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,22152,109,1.00 [0.82-1.22],0.9794833465914662
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,19670,99,0.63 [0.33-1.20],0.161860392065117
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",19619,98,0.75 [0.34-1.67],0.4856404500885258
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,22635,116,1.07 [0.89-1.30],0.4626750441842209
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,22152,109,0.99 [0.80-1.24],0.960520082851138
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,19133,94,1.19 [0.96-1.49],0.1171783670186546
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,21969,111,0.90 [0.70-1.16],0.4346493296155473
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,19693,96,0.93 [0.85-1.00],0.0638664332016711
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19353,94,0.88 [0.64-1.20],0.416157846268365
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,19186,95,0.94 [0.73-1.21],0.6300400933660939
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,22570,117,1.31 [0.80-2.13],0.283646214271237
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,19353,94,0.90 [0.70-1.17],0.4301406799263344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,19133,94,1.35 [0.92-1.98],0.1267109081360654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,22779,117,1.05 [0.80-1.38],0.7046701993507485
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",22266,114,0.93 [0.78-1.12],0.4632950560082294
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,22918,116,1.03 [0.65-1.64],0.8998976268239159
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,22628,113,0.89 [0.67-1.17],0.3882048646843387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,22266,114,1.08 [0.88-1.33],0.4592173175139561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,19040,95,0.82 [0.51-1.32],0.4194128642722977
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",19133,94,1.04 [0.79-1.38],0.7635573118597917
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",22796,114,0.92 [0.74-1.15],0.4795806862110565
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,22868,114,0.99 [0.87-1.12],0.8208850980668512
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",22679,117,0.99 [0.80-1.22],0.9348164816215736
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,22835,114,1.42 [1.09-1.83],0.0081450707482652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,22679,117,1.45 [0.92-2.29],0.1112934865389753
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,22796,114,0.94 [0.75-1.19],0.6199440824236473
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,22868,114,0.89 [0.67-1.18],0.4278018512661407
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,19732,96,0.98 [0.81-1.18],0.809353593360278
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,19133,94,0.97 [0.67-1.42],0.8930259565752865
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,22918,116,0.91 [0.68-1.22],0.516643466096055
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,19188,99,0.99 [0.71-1.38],0.9460791111358274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,19124,93,0.89 [0.62-1.26],0.4988693223015507
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,19632,95,1.02 [0.66-1.58],0.9239181740346076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,22839,114,0.88 [0.74-1.04],0.1400644760323536
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,19693,96,0.99 [0.73-1.35],0.9442370697711722
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,22266,114,0.91 [0.66-1.25],0.5498096086538651
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,19322,96,1.85 [0.88-3.89],0.1068366791862128
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,19693,96,1.33 [0.83-2.14],0.2424162320038753
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,19732,96,1.65 [0.76-3.59],0.2071913764003408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,22628,113,0.96 [0.78-1.18],0.6899213299685361
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,22918,116,1.39 [0.87-2.23],0.1671130455657438
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,19546,99,1.06 [0.54-2.06],0.8625739397268534
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,22152,109,0.97 [0.78-1.21],0.7749610628168851
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,19693,96,1.09 [0.84-1.41],0.516398283484978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,19188,99,1.18 [0.94-1.49],0.1536925697970407
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,19133,94,1.19 [0.70-2.00],0.5198551217062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,19658,96,1.06 [0.68-1.65],0.8098183380916781
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,19702,96,0.96 [0.61-1.49],0.8397569699119027
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,22266,114,1.13 [0.63-2.02],0.6822729133988013
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",19702,96,0.85 [0.47-1.54],0.5918100468841895
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",22561,112,1.15 [0.73-1.81],0.539250157292487
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",22628,113,2.04 [1.22-3.41],0.0065724094668526
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,22868,114,1.03 [0.72-1.48],0.8628748422374866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,19286,96,1.05 [0.74-1.49],0.77381573794832
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",19233,94,1.14 [0.78-1.67],0.5083430275247134
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",19133,94,1.12 [0.73-1.73],0.5941318917021416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,19011,94,1.00 [0.67-1.49],0.9811380110975432
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,22420,115,1.00 [0.70-1.44],0.9795994160739966
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,22105,111,0.83 [0.56-1.25],0.377842041490098
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,19186,95,0.94 [0.69-1.27],0.6737346693198414
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,22395,108,1.07 [0.75-1.54],0.6989416369161718
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,22199,112,1.05 [0.85-1.30],0.634882068609405
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,19702,96,0.76 [0.49-1.19],0.2303020605283561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,22918,116,0.99 [0.79-1.23],0.9055710816943902
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,22152,109,0.66 [0.42-1.06],0.0830813950114056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,19453,98,1.07 [0.86-1.32],0.5461463002891245
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,19317,94,1.05 [0.87-1.25],0.6233147583378557
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,19233,94,1.11 [0.67-1.83],0.682344338750126
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,19647,99,1.06 [0.57-1.97],0.8518934681702182
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,19233,94,0.93 [0.74-1.17],0.53916044541581
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,22564,113,1.16 [0.75-1.77],0.5092543642940803
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,22868,114,1.16 [0.73-1.86],0.5261481846330079
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,19188,99,0.98 [0.52-1.86],0.9587666387728252
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,19233,94,0.93 [0.76-1.15],0.5138598614065344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,22628,113,1.18 [0.77-1.80],0.4538330536214728
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,19693,96,0.86 [0.63-1.17],0.3324503000037376
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,19133,94,1.22 [0.85-1.75],0.2822707504652282
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,19233,94,0.86 [0.56-1.32],0.4782205579807072
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,22003,111,0.98 [0.76-1.26],0.8734924400019413
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,22740,117,0.92 [0.73-1.16],0.4778758979569449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,19627,96,0.94 [0.51-1.73],0.832747169911112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,22303,115,1.00 [0.78-1.28],0.9988924029234052
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,22868,114,1.15 [0.73-1.81],0.5394704145363531
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,22477,118,1.55 [0.85-2.86],0.15584493482825
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,19124,93,1.12 [0.91-1.37],0.3002222026247144
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,19124,93,0.90 [0.55-1.46],0.6616232930851322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",22740,117,0.92 [0.70-1.20],0.5309164645055202
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,22506,117,0.87 [0.43-1.79],0.7145220960446961
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,22941,117,1.08 [0.51-2.29],0.8349147186478699
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,22241,113,1.04 [0.84-1.28],0.7293901869585668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,22555,117,1.21 [0.68-2.13],0.5206748784650093
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,22941,117,0.76 [0.46-1.26],0.2870458972069888
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,22941,117,0.48 [0.25-0.92],0.026989477718063
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,22628,113,0.82 [0.60-1.12],0.208403359167109
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,22670,116,1.06 [0.73-1.54],0.7466709521578636
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,22564,113,0.62 [0.26-1.49],0.2860182270835033
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,19353,94,1.17 [0.81-1.69],0.4006291535831474
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,22105,111,1.21 [0.87-1.68],0.2643884132529992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",19233,94,0.92 [0.68-1.26],0.621691395827431
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,22918,116,1.03 [0.15-7.05],0.9792510513589664
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,22868,114,0.95 [0.66-1.36],0.7585951500205569
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19149,93,1.31 [0.79-2.14],0.292766421135566
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,19353,94,1.30 [0.95-1.79],0.1012027767240786
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,19353,94,1.11 [0.66-1.84],0.6973086183967829
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,19632,95,0.59 [0.26-1.35],0.2122659425060654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,22241,113,1.03 [0.89-1.20],0.6814252215464316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,22774,117,1.15 [0.51-2.56],0.7378203973912973
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,22514,109,0.93 [0.66-1.30],0.6538932309556361
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,22105,111,0.97 [0.66-1.42],0.8671524444671062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,19124,93,0.70 [0.46-1.07],0.0964089683364362
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,22628,113,1.26 [0.85-1.87],0.2546641329637417
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,19133,94,1.14 [0.71-1.84],0.5883671181628779
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,19186,95,0.99 [0.63-1.56],0.9605994214443464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,19702,96,0.85 [0.62-1.17],0.3254663605961204
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,19124,93,1.16 [0.81-1.65],0.4129503297816332
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,19730,98,0.88 [0.41-1.89],0.7480823747392393
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,22564,113,0.68 [0.30-1.53],0.3511378147205481
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,19133,94,1.16 [0.80-1.69],0.4233286686872775
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,22679,117,1.71 [0.84-3.51],0.1411461227072385
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,22902,117,1.00 [0.87-1.15],0.970414776470176
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,22901,116,1.07 [0.82-1.39],0.6393326688952805
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,22734,118,1.39 [0.76-2.55],0.2847020229425245
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,22380,113,1.55 [1.08-2.22],0.016970772795158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,22552,118,1.34 [0.77-2.32],0.3001065929561424
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,22941,117,2.11 [1.32-3.36],0.0018461981131132
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,22670,116,1.42 [0.89-2.26],0.1397275161526772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,19188,99,0.97 [0.75-1.26],0.8418624390200735
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,19133,94,1.11 [0.80-1.55],0.5254618442516952
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,19725,99,0.72 [0.29-1.82],0.4863492733034832
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,19040,95,1.09 [0.91-1.30],0.369407875034589
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,19233,94,0.71 [0.40-1.26],0.241684754105539
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,22564,113,1.43 [0.90-2.26],0.1275904686735198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,22670,116,0.99 [0.57-1.73],0.978306467475998
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,19732,96,1.13 [0.89-1.43],0.328384667684656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,22628,113,0.95 [0.80-1.14],0.6146812017416681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,22152,109,1.14 [0.97-1.33],0.1050160955213169
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,22241,113,1.11 [0.93-1.33],0.235785091480658
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,22241,113,1.24 [1.01-1.52],0.0391686208612839
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,22774,117,1.01 [0.57-1.80],0.9721842722870648
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,22241,113,0.99 [0.76-1.29],0.9494271153142794
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,22564,113,1.15 [0.94-1.42],0.1743777957805227
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,22918,116,1.21 [0.90-1.64],0.2054806788264694
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,22241,113,1.25 [0.81-1.93],0.3220570652185607
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,19188,99,0.83 [0.51-1.36],0.4624528013528796
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,22241,113,1.35 [1.10-1.66],0.0036256052211207
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,22382,113,0.48 [0.21-1.09],0.0783950785559436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,19124,93,0.89 [0.45-1.78],0.7421561766170612
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,22628,113,1.78 [1.11-2.84],0.0163816933934823
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,22241,113,1.40 [0.87-2.25],0.170415823862907
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,22918,116,0.65 [0.43-1.00],0.0503075038293616
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,22217,113,0.96 [0.65-1.42],0.8409816093952256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,22241,113,1.04 [0.83-1.31],0.7076072041505732
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,22241,113,0.94 [0.55-1.61],0.8337879042482123
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,22241,113,0.99 [0.80-1.22],0.9253149682637049
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,22679,117,1.41 [0.97-2.04],0.070992117603201
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,22334,112,1.05 [0.76-1.44],0.7855958342469329
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,22588,115,1.01 [0.72-1.44],0.9395619971973872
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,22734,118,1.11 [0.66-1.89],0.6867630531468853
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,22918,116,1.40 [0.86-2.27],0.1768297525016056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,22366,107,0.95 [0.86-1.05],0.2968175049139902
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,22105,115,1.04 [0.82-1.32],0.7347905906763288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,22241,113,1.17 [0.91-1.51],0.2123080868635407
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,22140,113,1.10 [0.84-1.46],0.4842807172379586
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,22645,117,0.96 [0.46-2.00],0.9188959477524852
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,22634,115,1.91 [0.80-4.56],0.1430563980322641
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,22679,117,0.94 [0.64-1.36],0.7320810465286474
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,22873,117,1.01 [0.70-1.45],0.9613466066447702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,22241,113,1.00 [0.65-1.53],0.9932310464006292
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,22631,117,1.03 [0.77-1.37],0.8593863465332385
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,22241,113,1.17 [0.68-2.00],0.5697215096741286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,22241,113,0.82 [0.56-1.19],0.2957651482530223
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,22241,113,1.13 [0.82-1.55],0.4686316819353473
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,19188,99,1.03 [0.65-1.64],0.8999332898086283
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,19188,99,1.11 [0.81-1.52],0.5040222043717899
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,19627,96,0.87 [0.64-1.19],0.3876190031560945
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,22241,113,1.04 [0.71-1.51],0.8403982240366582
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,22241,113,1.23 [0.93-1.62],0.1433040313177996
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,18970,95,1.18 [0.67-2.10],0.5653206464364475
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,22500,116,1.62 [1.10-2.39],0.0139800808167987
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,22241,113,1.07 [0.72-1.58],0.7394683208060084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,19627,96,0.97 [0.59-1.62],0.9220481587118098
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,19040,95,1.69 [1.18-2.41],0.0039286086456007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,19188,99,0.92 [0.64-1.32],0.637515104193475
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,19113,99,0.93 [0.58-1.52],0.785389040049636
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,22628,113,1.26 [0.87-1.84],0.2243784414530772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,22241,113,1.00 [0.65-1.54],0.9879720328885884
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,22075,111,0.86 [0.55-1.36],0.5258792162778863
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,19188,99,0.94 [0.66-1.34],0.7188285551122182
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,19106,99,0.84 [0.61-1.16],0.2860466649459939
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,22241,113,1.15 [0.69-1.92],0.5867343234380165
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,22241,113,1.03 [0.85-1.25],0.7551560795469766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,22628,113,0.89 [0.55-1.43],0.620213285052778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,22241,113,1.01 [0.90-1.13],0.9059817932501902
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,22628,113,0.89 [0.65-1.21],0.4586988509208571
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,22564,113,0.99 [0.79-1.24],0.9138759685230312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,22511,117,0.55 [0.34-0.90],0.0163904959781769
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,22670,116,0.43 [0.16-1.13],0.0861093494190164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,22628,113,0.91 [0.70-1.18],0.4951232086890738
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,22679,117,0.85 [0.63-1.15],0.2907533226241681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,19353,94,0.99 [0.69-1.41],0.9482251284213812
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,22080,111,0.84 [0.62-1.15],0.2732785153238491
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,19627,96,0.62 [0.37-1.04],0.0706464162715104
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,22514,109,0.94 [0.71-1.24],0.6624652672926465
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,19693,96,0.96 [0.68-1.34],0.7929710260394693
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,19124,93,0.67 [0.32-1.42],0.2930307501780987
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,22056,110,0.80 [0.53-1.20],0.2785910851438977
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,19322,96,1.32 [0.92-1.90],0.1329026826736355
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,22679,117,1.15 [0.78-1.69],0.4754108438125821
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,22564,113,0.97 [0.71-1.33],0.8705790999408415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",19233,94,0.77 [0.53-1.10],0.1482664229351224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",19702,96,0.78 [0.47-1.28],0.3237133965487371
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",22564,113,1.03 [0.87-1.22],0.7364330441289386
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,19693,96,0.98 [0.71-1.36],0.9125425224204886
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,19627,96,0.82 [0.53-1.28],0.3836698942526418
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,19632,95,1.03 [0.84-1.27],0.7854054010691504
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,19188,99,1.27 [0.40-4.00],0.6825797901007147
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,22479,109,0.91 [0.75-1.09],0.3048252294380085
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,22564,113,0.81 [0.59-1.11],0.1923234264366271
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",22266,114,0.92 [0.75-1.12],0.396459764938733
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,22241,113,0.99 [0.77-1.26],0.9313286750307772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,22628,113,1.02 [0.87-1.19],0.8409014844364306
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,21795,109,0.81 [0.51-1.29],0.3781995693942352
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,22628,113,0.76 [0.49-1.18],0.2191692238712761
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,19730,98,1.14 [0.75-1.73],0.5436416058020856
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,19492,95,0.93 [0.76-1.13],0.4547235237648754
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,22628,113,0.63 [0.39-1.02],0.0603474936856132
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,19322,96,0.61 [0.35-1.08],0.0913870754494215
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,22679,117,1.28 [0.66-2.46],0.4653221040615948
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,22628,113,0.83 [0.59-1.15],0.266055679511426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,19188,99,0.96 [0.62-1.49],0.8510248036485111
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,22679,117,0.55 [0.32-0.93],0.0253901868905137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,22868,114,0.74 [0.38-1.43],0.367521996752576
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,19353,94,1.11 [0.79-1.56],0.5461872420419125
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,22626,118,0.49 [0.23-1.04],0.0635367104572275
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,22152,109,1.09 [0.72-1.64],0.6799334330349494
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,22266,114,1.08 [0.93-1.26],0.2986826137440976
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,22519,113,0.59 [0.33-1.08],0.089089420024451
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,22740,117,0.69 [0.44-1.10],0.1173022253602682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,22241,113,1.25 [0.71-2.19],0.4462307420962973
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,22868,114,0.91 [0.63-1.31],0.5967350632069799
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,19730,98,1.55 [0.92-2.59],0.096448986762147
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,19764,99,1.03 [0.38-2.81],0.9502740046885774
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,22734,118,0.92 [0.59-1.42],0.7043295481358199
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,19764,99,0.74 [0.35-1.56],0.4302888378319022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,19627,96,1.10 [0.73-1.67],0.6357453389112451
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,22628,113,1.14 [0.87-1.50],0.3487486942635878
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,19133,94,1.15 [0.86-1.53],0.352808650677173
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",19233,94,0.98 [0.74-1.30],0.8869410047149459
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",19124,93,1.05 [0.68-1.63],0.8121853182686408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",22105,111,1.04 [0.74-1.45],0.820223779572462
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,19040,95,0.98 [0.65-1.49],0.9314231625560664
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,22868,115,1.62 [0.87-2.99],0.1257337314289396
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,19322,96,1.35 [0.94-1.93],0.1065188980137846
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,22241,113,1.13 [0.86-1.48],0.3699854236061736
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,19040,95,0.70 [0.47-1.06],0.0900999879542427
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,19632,95,0.96 [0.76-1.20],0.6956821209928981
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,22241,113,0.99 [0.71-1.39],0.974130971534139
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,22564,113,1.18 [0.80-1.72],0.4015130484565204
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,19632,95,0.91 [0.75-1.09],0.2989162003110996
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,19124,93,1.20 [0.90-1.60],0.2127874310650133
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,19186,95,0.95 [0.72-1.24],0.6957290419326984
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,22105,111,1.07 [0.78-1.48],0.6650519994416713
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,19328,93,1.07 [0.69-1.67],0.7590942233123305
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,19188,99,1.11 [0.92-1.34],0.2642541474189326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,22740,117,0.51 [0.27-0.96],0.0364758338410829
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,22105,111,0.79 [0.49-1.26],0.3258722590718462
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,19040,95,1.00 [0.75-1.33],0.9912615249639254
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,19233,94,0.92 [0.67-1.26],0.6094611273499033
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,19693,96,1.93 [1.15-3.26],0.013495501695231
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,19353,94,1.00 [0.75-1.32],0.983468856006976
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,19353,94,0.90 [0.45-1.81],0.7719326086600249
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,19627,96,0.78 [0.51-1.20],0.2578937263940118
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,19133,94,1.19 [0.74-1.92],0.4637744815426783
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,19124,93,0.88 [0.67-1.16],0.3612580272319489
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,19133,94,1.01 [0.86-1.19],0.9286486073109615
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,22564,113,0.97 [0.79-1.18],0.732696145963978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,19627,96,1.23 [0.99-1.54],0.0660290830179643
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,22152,109,1.08 [0.87-1.34],0.4721860530874695
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,19632,95,1.10 [0.99-1.23],0.0781217386221019
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,22152,109,0.98 [0.85-1.12],0.7642379236671566
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,19040,95,0.90 [0.69-1.17],0.4274322824955973
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,19124,93,0.97 [0.69-1.37],0.8641124434314993
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,22105,111,1.35 [0.89-2.06],0.155181469671356
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,22697,118,0.95 [0.55-1.64],0.8438217751574649
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,22670,116,0.66 [0.43-1.03],0.0644824954083297
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,22105,111,0.89 [0.71-1.12],0.3269015478616167
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,19124,93,0.98 [0.59-1.65],0.9504580593687968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,19702,96,1.38 [0.99-1.93],0.0576783955190234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,22430,115,1.04 [0.91-1.17],0.5897945285958671
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,22667,116,0.83 [0.55-1.26],0.3865273903590477
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,22516,116,0.97 [0.56-1.68],0.9212155951496724
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,22152,109,1.09 [0.97-1.23],0.1653493758976209
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,22167,113,1.36 [0.94-1.96],0.0985358871407221
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,22868,114,0.77 [0.54-1.10],0.1490943952894466
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,19601,95,1.65 [1.18-2.32],0.0038267526920901
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,19730,98,1.30 [0.99-1.70],0.0563943591948603
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,22868,114,0.91 [0.69-1.21],0.5201818567427747
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,22712,116,0.71 [0.42-1.22],0.2145670506160759
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,18802,96,1.58 [1.01-2.49],0.0474922526172548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,21908,112,0.99 [0.61-1.58],0.9520895087431116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,19365,98,0.71 [0.33-1.53],0.3801196079759887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,22918,116,0.90 [0.58-1.39],0.6264046811934793
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,19124,93,0.90 [0.62-1.31],0.5771744185337594
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,22918,116,1.13 [0.79-1.61],0.5113830066603526
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,19188,99,0.87 [0.53-1.44],0.5962615906453681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,19693,96,1.02 [0.67-1.55],0.9311649575707288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",21377,106,1.06 [0.58-1.95],0.8390851251145005
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",19133,94,1.78 [1.23-2.59],0.0023537257882481
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",22564,113,1.02 [0.83-1.27],0.8288025832528971
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",22595,113,1.11 [0.87-1.41],0.4075708642783811
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",22105,111,1.24 [0.90-1.73],0.1893773501507857
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",19133,94,1.31 [0.87-1.97],0.1948189410929439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",19124,93,1.08 [0.81-1.43],0.6058857458289446
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,22631,116,1.01 [0.76-1.34],0.964254117583694
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,22918,116,0.91 [0.63-1.32],0.6283333611906163
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,22740,117,0.81 [0.45-1.44],0.4656677296601116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,19732,96,0.95 [0.76-1.18],0.6361711480423998
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,19590,96,1.21 [0.87-1.67],0.257763277599192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,22670,116,0.99 [0.77-1.27],0.9322635854574076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,22564,113,1.17 [0.78-1.75],0.4464611945080793
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22663,115,1.36 [0.87-2.13],0.1787999976882701
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,22514,109,1.17 [0.99-1.40],0.0712846195584746
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,19133,94,1.02 [0.71-1.45],0.9306535271556376
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,22774,117,1.25 [0.77-2.04],0.3665341025569889
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,19233,94,1.11 [0.57-2.19],0.7519571013110022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,19181,98,1.10 [0.60-2.00],0.7624663526031918
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,21976,107,1.55 [0.60-4.01],0.3663782257847477
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,22878,116,1.17 [0.86-1.60],0.3223944352723611
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,19627,96,0.78 [0.47-1.30],0.3440191302965389
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,22241,113,1.20 [0.87-1.66],0.2723352569064846
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,19627,96,0.85 [0.61-1.19],0.3455354998202088
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,22918,116,0.98 [0.79-1.21],0.8319677375289231
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,22564,113,1.01 [0.88-1.16],0.8684434636174206
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,19188,99,1.03 [0.82-1.30],0.8151301962681937
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,22465,108,1.70 [1.07-2.71],0.0254239781951778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,22734,118,1.01 [0.76-1.33],0.953676553095445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,22868,115,0.96 [0.75-1.23],0.749548793052538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,19739,99,0.78 [0.36-1.70],0.5314847678033029
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,19702,96,1.12 [0.84-1.50],0.4229717042177013
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,21969,118,1.09 [0.72-1.67],0.6748858695237699
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,19730,98,0.96 [0.63-1.44],0.8281144602844576
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,22732,117,0.80 [0.58-1.09],0.1569401539414101
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,19702,96,1.01 [0.82-1.23],0.9491350813242329
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,19732,96,1.08 [0.81-1.45],0.5950994681654714
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,22829,114,0.92 [0.66-1.28],0.6136321192812473
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,18659,92,1.20 [0.90-1.60],0.2083790344253582
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,19124,93,1.09 [0.85-1.40],0.4834080759767699
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,19702,96,1.53 [1.12-2.09],0.0076139828659324
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEP,Leptin,22670,116,0.82 [0.64-1.06],0.1223085762897904
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,22670,116,0.63 [0.36-1.12],0.1148003326732352
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,19702,96,0.98 [0.67-1.44],0.9203109532734808
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,22670,116,1.14 [0.71-1.85],0.5826532732174043
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,22722,115,0.89 [0.51-1.54],0.6728917888563326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,19764,99,0.94 [0.49-1.82],0.8629116419247643
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,22663,115,1.30 [0.97-1.75],0.084132208856679
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,22630,113,1.36 [0.94-1.98],0.1052822900921357
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,22868,115,1.01 [0.77-1.33],0.9455899674233202
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,22666,116,1.47 [0.89-2.41],0.1299419359664211
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,22774,117,1.36 [0.87-2.12],0.1721527590339478
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,22152,109,1.17 [0.99-1.39],0.0691888575522675
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,22699,117,0.94 [0.71-1.24],0.6426827597937124
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,22105,111,1.10 [0.81-1.49],0.5373445891323476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,22628,113,0.95 [0.48-1.90],0.8852047121127555
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,22679,117,0.73 [0.46-1.13],0.1596269489793932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,19730,98,1.08 [0.92-1.27],0.3671123094968765
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,19133,94,0.94 [0.63-1.40],0.7534105778644477
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22636,116,1.09 [0.65-1.84],0.7441280063018816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,19732,96,1.14 [0.87-1.49],0.3348476532433397
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,22941,117,1.23 [0.68-2.25],0.4925543089620519
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,22833,116,1.16 [0.71-1.87],0.5560250652744213
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22241,113,1.64 [1.14-2.35],0.0079594009646271
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,22941,117,0.93 [0.74-1.16],0.4963918387176732
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,19233,94,0.90 [0.65-1.26],0.5395798105347778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,19589,95,1.00 [0.72-1.38],0.976284599857879
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,19693,96,1.37 [0.70-2.70],0.3609411552131057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,19702,96,1.50 [0.99-2.28],0.053257449461457
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,19124,93,0.83 [0.59-1.18],0.3098344445520703
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",19233,94,0.87 [0.69-1.11],0.2576756543530605
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),19269,96,1.06 [0.95-1.19],0.268125186505307
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,22564,113,0.95 [0.62-1.46],0.8231640795660575
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,22670,116,0.87 [0.61-1.23],0.4201259976483417
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,21959,104,1.24 [0.93-1.67],0.1449103225068263
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,19133,94,0.95 [0.70-1.29],0.7607653272970005
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,19133,94,1.01 [0.75-1.35],0.9500600687806002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,19186,95,0.90 [0.58-1.39],0.6277821247448285
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,19764,99,1.15 [0.56-2.39],0.7025478643727299
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,22796,114,0.97 [0.60-1.58],0.9063262054960388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,19113,99,1.19 [0.65-2.20],0.5715498679405927
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,22564,113,1.27 [0.68-2.35],0.4556275744477661
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,22670,116,1.07 [0.68-1.70],0.7627611043241158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,19186,95,1.18 [0.73-1.92],0.4985570715100289
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,19186,95,0.99 [0.79-1.24],0.958582435563666
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,22868,115,1.22 [0.96-1.55],0.1059787037555039
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,22564,113,1.02 [0.66-1.56],0.9424991482908682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,19632,95,1.14 [0.72-1.80],0.5858878184727498
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,19186,95,1.29 [0.92-1.81],0.1463080119513164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,19732,96,0.98 [0.65-1.48],0.9195719723702866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,19627,96,0.83 [0.54-1.26],0.3779103489073859
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,22241,113,0.74 [0.48-1.14],0.1695161308889127
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19186,95,0.97 [0.59-1.59],0.9005230528645757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,19702,96,0.74 [0.35-1.58],0.4337436406778829
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,22152,109,0.86 [0.62-1.20],0.3799309969676406
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,19353,94,0.83 [0.63-1.09],0.1853972655701435
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,22628,113,0.79 [0.52-1.22],0.2918846035426782
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,22628,113,0.93 [0.61-1.40],0.7159026803854797
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,22868,114,0.80 [0.60-1.07],0.1373367562760216
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,19627,96,0.90 [0.50-1.62],0.7235880820333213
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,22941,117,1.54 [0.93-2.56],0.0906139200119901
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,22152,109,0.89 [0.63-1.25],0.5084944227139696
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,22561,115,1.31 [0.73-2.36],0.3684430722574439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,22241,113,0.95 [0.63-1.44],0.8088715998790871
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,19627,96,0.90 [0.57-1.42],0.6457353451991594
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LXN,Latexin,22410,108,0.84 [0.64-1.11],0.2182576738746735
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,22563,116,1.31 [0.87-1.97],0.2026039703829007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,22628,113,0.77 [0.51-1.17],0.2228309272998687
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,22450,114,0.98 [0.55-1.75],0.9352678252415418
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,22514,109,0.64 [0.38-1.06],0.0850080132140466
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,22152,109,0.79 [0.54-1.16],0.2249985294756126
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,22564,113,1.05 [0.86-1.28],0.6385461417692473
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,22105,111,0.84 [0.61-1.16],0.2990127634096825
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,22553,117,0.63 [0.38-1.04],0.0696597818906271
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,22152,109,0.81 [0.56-1.17],0.2561369663550675
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,19124,93,0.98 [0.81-1.19],0.8728203367637624
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,19186,95,1.09 [0.92-1.30],0.3162995311776703
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,19764,99,0.75 [0.28-1.96],0.5531781556778823
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,19040,95,1.21 [0.72-2.02],0.4787582163447939
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,19322,96,1.09 [0.83-1.43],0.5581266516165722
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,19233,94,0.79 [0.45-1.39],0.4131401364426024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22429,108,0.98 [0.68-1.41],0.9146803994705242
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,22152,109,0.85 [0.54-1.34],0.4857334370833558
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,19186,95,0.97 [0.64-1.47],0.8880828196822638
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,19353,94,0.93 [0.75-1.16],0.5094744719151065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,22152,109,0.77 [0.53-1.12],0.1766886910618453
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,19732,96,1.24 [0.71-2.16],0.4493098127854688
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,19627,96,1.13 [0.79-1.61],0.5038142258297611
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",19233,94,1.63 [0.74-3.59],0.2204361406823331
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,19732,96,1.03 [0.74-1.43],0.8815918054981999
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",19040,95,0.71 [0.48-1.07],0.1023838900253674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,22774,117,1.01 [0.88-1.16],0.8804530420223757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,22740,117,0.64 [0.35-1.18],0.1530460278061634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,19133,94,0.81 [0.60-1.10],0.1853637537466796
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,19124,93,0.65 [0.34-1.23],0.1825065199209234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,19133,94,1.25 [1.02-1.55],0.033075610619408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,19693,96,0.90 [0.58-1.41],0.6440025990952027
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,19632,95,0.92 [0.68-1.25],0.5988073230951569
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,22628,113,0.94 [0.79-1.10],0.4369120248488497
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,22152,109,0.96 [0.80-1.14],0.6148423128757421
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,22465,108,1.00 [0.86-1.16],0.9691720102354392
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,19040,95,1.20 [0.80-1.79],0.378245635045344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,22628,113,0.77 [0.52-1.13],0.1805238478924432
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,19353,94,1.00 [0.76-1.31],0.9823044872708234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,19040,95,0.99 [0.86-1.14],0.8707529261443939
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,22105,111,1.01 [0.74-1.39],0.9304579121045118
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,22670,116,1.24 [0.66-2.31],0.5028162091695524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",19279,96,1.00 [0.79-1.26],0.9981379116615746
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,22465,108,1.07 [0.51-2.24],0.8507556814985674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,22706,116,1.22 [0.70-2.12],0.4926079952512225
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,22479,109,0.96 [0.56-1.66],0.8898130371433653
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,22152,109,1.00 [0.83-1.21],0.9758821747572184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAX,Protein max,22105,111,1.00 [0.85-1.17],0.9864474827304124
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,22941,117,1.33 [0.98-1.79],0.0670972377669354
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,19475,97,1.19 [0.98-1.43],0.0735638594033605
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,22734,118,0.74 [0.46-1.20],0.2201824347915872
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",19702,96,0.93 [0.58-1.49],0.7616236072356086
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,19188,99,1.05 [0.85-1.29],0.6518309922281343
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,22572,115,1.08 [0.74-1.59],0.6845257758443328
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,19632,95,0.83 [0.37-1.85],0.6487320312753454
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,22514,109,0.90 [0.71-1.14],0.3748743229287886
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",19618,99,0.99 [0.62-1.58],0.9576914169221108
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MDK,Midkine,22680,116,1.06 [0.78-1.43],0.7279460873633115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,19186,95,1.35 [0.74-2.47],0.3328866538371731
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",19233,94,0.94 [0.76-1.18],0.6093552457689915
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,22152,109,0.99 [0.79-1.23],0.9017183624978324
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,19133,94,1.00 [0.67-1.48],0.9825526060352628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,22663,115,0.66 [0.42-1.02],0.0614716679724169
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,19133,94,1.42 [0.93-2.17],0.102098828680856
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,22873,117,0.62 [0.27-1.42],0.2593296070433428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,19732,96,0.55 [0.28-1.09],0.0876398970329628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,19322,96,0.89 [0.36-2.20],0.802156150581065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,19632,95,1.09 [0.82-1.45],0.5554843943313303
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,22670,116,0.88 [0.77-1.00],0.0552733435039474
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,22663,115,0.81 [0.44-1.48],0.4954606469283755
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,22918,116,1.22 [0.65-2.27],0.5351063671737276
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,22679,117,0.99 [0.87-1.13],0.89029427158135
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,22726,115,1.17 [0.52-2.63],0.7052357832934264
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,22105,111,0.95 [0.53-1.70],0.8559313574284895
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",22628,113,0.98 [0.80-1.20],0.8603910479613621
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,22829,114,0.81 [0.62-1.07],0.1386153010994424
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,22266,114,1.08 [0.79-1.48],0.6261708981999431
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,19186,95,1.27 [1.03-1.56],0.0231174828229713
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,19322,96,1.57 [0.85-2.92],0.1513125280258221
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,22941,117,1.06 [0.71-1.59],0.7615151321822797
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,22679,117,1.37 [0.95-2.00],0.0950646985057439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,22734,116,1.01 [0.83-1.22],0.9452479287337208
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,22628,113,1.00 [0.88-1.15],0.9536101095980304
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,22740,117,1.16 [0.75-1.78],0.5107213972358633
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,19186,95,0.95 [0.71-1.27],0.7173305263291823
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,22628,113,0.95 [0.86-1.05],0.3337923604907256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,22649,117,0.91 [0.72-1.15],0.4138110903775608
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,22241,113,1.02 [0.73-1.42],0.9131131377209296
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,19627,96,0.92 [0.77-1.10],0.3577580920370611
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,19693,96,0.94 [0.76-1.16],0.5437750434204698
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,22514,109,0.98 [0.82-1.17],0.8362019532892069
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,19188,99,1.11 [0.71-1.74],0.6477580849928245
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,19040,95,1.10 [0.84-1.43],0.4930828313713508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,22628,113,1.10 [0.91-1.33],0.3226655984643903
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,22564,113,1.03 [0.84-1.26],0.7762407351829377
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,21801,112,1.06 [0.88-1.28],0.547694104545438
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,22633,116,0.86 [0.65-1.15],0.3095400673420753
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,22688,114,1.02 [0.74-1.39],0.9195933046707172
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,22105,111,1.29 [0.78-2.15],0.3206173168324052
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,19732,96,1.20 [0.88-1.63],0.2443103663614821
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,22679,117,1.16 [0.83-1.61],0.3811423001585677
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,22225,114,1.84 [1.28-2.63],0.0008638896716654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,22828,115,0.94 [0.75-1.17],0.5717198896503941
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,22638,117,1.01 [0.77-1.32],0.9494737052117088
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",19133,94,1.15 [0.77-1.70],0.4981648053685686
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,19186,95,1.09 [0.80-1.48],0.5897405377512868
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,19353,94,0.96 [0.61-1.52],0.8693964826614573
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,22635,116,0.92 [0.77-1.09],0.3245483319126301
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,19322,96,1.13 [0.85-1.51],0.3997164828329411
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,22868,114,0.89 [0.53-1.48],0.6416886914140607
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,19693,96,0.77 [0.36-1.67],0.5126935803490429
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,19353,94,1.07 [0.69-1.67],0.7550650672173482
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,19040,95,0.97 [0.57-1.65],0.9079181523183346
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,19040,95,1.02 [0.80-1.31],0.8612431065198969
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,22266,114,0.99 [0.80-1.24],0.94995387624102
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,22564,113,0.96 [0.79-1.16],0.6502955743929126
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,22734,116,0.96 [0.78-1.19],0.7260576000335729
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,22679,117,1.02 [0.73-1.44],0.8940720254650855
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,19584,96,0.89 [0.57-1.40],0.6184666670006735
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,19739,99,1.68 [0.89-3.17],0.1111864719853728
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,19186,95,0.85 [0.64-1.12],0.2509296477737489
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",19133,94,1.71 [1.31-2.23],8.737742475599761e-05
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",19702,96,1.08 [0.67-1.72],0.75692828207744
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",22105,111,0.69 [0.36-1.34],0.2780566353674488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",19011,94,1.02 [0.46-2.22],0.969201370079782
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",19702,96,0.84 [0.62-1.14],0.2674386933547812
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",19188,99,1.02 [0.53-1.97],0.9474537639792692
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,22533,113,1.15 [0.86-1.53],0.340653762708266
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,19186,95,0.83 [0.48-1.42],0.4922627812623114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,22582,116,1.00 [0.79-1.26],0.9875313072749377
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,22868,115,1.12 [0.77-1.62],0.561393841655987
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,22740,117,0.94 [0.75-1.17],0.5682468747965796
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,19426,98,1.17 [0.82-1.69],0.3856410376148379
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,22266,114,1.00 [0.72-1.39],0.9986738317876952
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,19188,99,1.05 [0.85-1.29],0.6770738664750175
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",19693,96,1.36 [0.70-2.63],0.3621027487782992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,19353,94,0.99 [0.83-1.18],0.9176986103812924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",19632,95,0.98 [0.78-1.23],0.8699637623569507
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,22266,114,1.16 [0.76-1.79],0.4908709408077898
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,19133,94,1.16 [0.90-1.49],0.2428649545057086
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,19632,95,0.97 [0.81-1.15],0.7081397214288628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,19627,96,0.97 [0.79-1.18],0.7283760028057227
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,19353,94,0.90 [0.62-1.30],0.5603524637460557
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,22105,111,0.96 [0.68-1.36],0.8185912128570995
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,22564,113,1.00 [0.91-1.09],0.9448167230547172
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,19730,98,0.90 [0.73-1.11],0.3385813501518829
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,19040,95,1.08 [0.72-1.64],0.7012571085231796
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,22241,113,1.04 [0.84-1.29],0.7382503257108415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,19322,96,1.10 [0.58-2.09],0.7707288809132031
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",19732,96,1.45 [1.12-1.89],0.0048941526085474
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",19233,94,1.16 [0.96-1.41],0.126376368474709
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,19702,96,0.80 [0.59-1.10],0.1770424804200098
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,19732,96,0.99 [0.81-1.20],0.9132790312159708
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,19133,94,1.30 [0.93-1.81],0.1234779213404858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,19040,95,0.96 [0.61-1.51],0.8557505255667774
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,19730,98,0.96 [0.81-1.14],0.6323784756900093
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",19133,94,1.10 [0.70-1.73],0.6683729740555215
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,19233,94,1.23 [0.93-1.63],0.1441795187861682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,19233,94,1.02 [0.71-1.47],0.9100063528357348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,19186,95,1.06 [0.87-1.30],0.5522005177047533
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",19186,95,1.09 [0.71-1.69],0.6848094675494856
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,19702,96,1.06 [0.62-1.79],0.8394700450921688
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,22241,113,0.84 [0.64-1.10],0.1983064461787368
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,22679,117,1.07 [0.75-1.54],0.7058266502194316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,19124,93,1.19 [0.84-1.69],0.3328786663984017
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,19133,94,1.13 [0.75-1.71],0.5638953725338033
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,19322,96,1.14 [0.92-1.41],0.2471871600234291
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,22746,117,1.30 [0.96-1.75],0.0891368269644981
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,22152,109,0.93 [0.66-1.30],0.6657176438246943
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,19133,94,0.86 [0.58-1.27],0.4415579582961222
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,19186,95,0.99 [0.84-1.17],0.915206398157774
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,22409,109,0.94 [0.70-1.27],0.6880854130761775
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,19627,96,0.91 [0.63-1.32],0.61433819811446
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,22670,116,1.08 [0.81-1.43],0.6002899228547822
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,19149,99,1.28 [0.99-1.65],0.0579697700065791
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,19196,94,0.91 [0.64-1.30],0.6009163020012812
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19322,96,2.10 [0.83-5.32],0.1159822004045027
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,22152,109,0.85 [0.60-1.22],0.3795110280284757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,19603,94,0.93 [0.58-1.48],0.7541560509281687
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,19693,96,0.72 [0.38-1.36],0.311778113971113
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",19702,96,0.97 [0.64-1.45],0.8672856954952656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,22740,117,1.13 [0.61-2.10],0.6965785123965954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,22241,113,0.71 [0.48-1.05],0.0867663557033007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,22734,118,0.81 [0.45-1.45],0.4725880681704565
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,22679,117,0.78 [0.42-1.43],0.4168176947812387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,22868,115,0.99 [0.64-1.54],0.9639452985248008
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,22600,113,0.86 [0.70-1.07],0.1766540534309656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,22774,117,1.01 [0.87-1.18],0.8815692527357722
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,22241,113,1.16 [0.89-1.52],0.2596218640604066
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,22594,112,1.14 [0.72-1.81],0.5833044420924115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,19632,95,1.14 [0.63-2.07],0.6625702387171257
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,22868,114,1.17 [0.65-2.10],0.5952232395416732
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,22105,111,1.10 [0.89-1.35],0.388414529753649
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,19627,96,1.09 [0.83-1.42],0.5501000122329829
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,19154,99,1.48 [0.87-2.51],0.1484540432705636
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,19632,95,0.90 [0.72-1.13],0.3601586991054134
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",22152,109,1.10 [0.90-1.35],0.3309997602502953
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,19133,94,1.39 [0.93-2.07],0.1062594947239061
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,19133,94,1.01 [0.76-1.35],0.9475031756208896
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,19188,99,1.01 [0.55-1.85],0.9696643390159378
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,22636,116,1.59 [0.91-2.76],0.1027474984819359
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,22740,117,1.15 [0.67-1.98],0.601241525404534
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,19188,99,1.02 [0.69-1.51],0.9224425145556164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,19188,99,0.85 [0.46-1.58],0.6056420844565071
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,22026,111,1.15 [0.77-1.73],0.4898912618250047
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,19353,94,1.07 [0.85-1.36],0.5535133738461071
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,22740,117,0.60 [0.41-0.88],0.0087471260033928
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,22774,117,1.39 [0.78-2.47],0.2585151456824982
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,19627,96,1.00 [0.84-1.19],0.9742680853596294
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,19702,96,1.09 [0.45-2.63],0.8525094000994458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,19739,99,1.00 [0.76-1.33],0.9883315753299
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,22918,116,2.24 [1.26-3.97],0.005969392114328
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,19188,99,0.87 [0.69-1.11],0.2682604118968414
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",22628,113,0.96 [0.81-1.15],0.6848501870680244
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",22241,113,1.15 [0.87-1.52],0.3394791829728016
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,19233,94,0.84 [0.64-1.10],0.2076530661385119
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,19702,96,1.02 [0.66-1.58],0.9263266338123416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,19133,94,0.89 [0.67-1.17],0.3977454865648694
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,19353,94,1.11 [0.83-1.49],0.4884875441962769
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,22152,109,0.84 [0.58-1.20],0.3422444985950717
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",19632,95,0.99 [0.81-1.20],0.9005610615246602
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,19133,94,0.95 [0.70-1.29],0.7479162406910282
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,19133,94,0.87 [0.50-1.51],0.6158598781577578
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,22514,109,0.53 [0.13-2.16],0.3773285516403126
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,19732,96,1.48 [0.91-2.42],0.1167951153580101
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,19693,96,0.78 [0.30-2.00],0.6062867672410777
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,18843,96,1.05 [0.56-1.99],0.8732835097612548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,22657,118,0.90 [0.60-1.36],0.6258422434201572
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,22679,117,0.96 [0.78-1.19],0.7233894045705839
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,22152,109,1.04 [0.78-1.41],0.7717137658822936
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,19233,94,0.93 [0.63-1.38],0.7250076077859305
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,19662,95,0.95 [0.73-1.23],0.6751821836687549
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,19186,95,1.03 [0.78-1.36],0.8297842544918668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,19124,93,1.20 [0.85-1.70],0.3031465637924249
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,19188,99,2.22 [1.04-4.74],0.0399427787402322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,22706,116,0.39 [0.19-0.80],0.0102290659035876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,19556,96,0.96 [0.73-1.27],0.7851588987266902
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,22514,109,0.82 [0.63-1.06],0.1275999021876846
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,19040,95,1.03 [0.66-1.62],0.8966938064855541
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,19702,96,1.00 [0.75-1.33],0.9866390013080918
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,22679,117,2.13 [1.11-4.06],0.0222173264995125
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,19133,94,1.07 [0.91-1.26],0.4221271957136132
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",22105,111,1.12 [0.79-1.59],0.5164878581138156
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",19133,94,1.03 [0.62-1.70],0.916246095682298
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",22105,111,1.25 [0.96-1.64],0.1008379412704581
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,22941,117,0.71 [0.25-2.08],0.5368289211606072
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,19730,98,1.10 [0.42-2.89],0.8510462734883345
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,22941,117,0.83 [0.52-1.34],0.448548603167985
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,19395,98,1.57 [0.94-2.62],0.082760403650316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,22670,116,1.13 [0.67-1.91],0.6465481680775053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,19188,99,0.59 [0.32-1.09],0.09228593923037
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,19188,99,1.02 [0.85-1.22],0.8572357062745408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,19732,96,1.73 [1.17-2.57],0.0064271108108625
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,22266,114,1.08 [0.95-1.23],0.243542259827415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,22628,113,1.45 [1.01-2.10],0.0464551829377577
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,19133,94,1.36 [0.90-2.05],0.1453539333369502
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,22152,109,1.04 [0.86-1.26],0.6837532471338715
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,22679,117,1.45 [0.97-2.17],0.0737624906444881
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,19730,98,2.03 [1.12-3.66],0.0188312044954259
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,22670,116,0.78 [0.47-1.28],0.3275746743336094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,22868,114,1.02 [0.79-1.31],0.8712603476121956
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,22670,116,1.03 [0.58-1.85],0.9117726852845478
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,19739,99,1.07 [0.87-1.32],0.5326600053953746
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,19702,96,0.77 [0.40-1.48],0.4354521489353413
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,22777,118,1.66 [0.95-2.93],0.0774248059593263
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,22679,117,1.46 [0.85-2.52],0.1669259345368682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,22241,113,1.15 [0.85-1.56],0.3605755431165736
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,19186,95,0.69 [0.36-1.34],0.273169672019153
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,22868,115,0.93 [0.73-1.19],0.5810537322602332
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",19732,96,1.03 [0.79-1.33],0.8517896484363218
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,19693,96,1.14 [0.64-2.04],0.6520409824457105
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,22598,113,0.92 [0.76-1.10],0.3608667543542682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,22740,117,0.70 [0.51-0.95],0.0234127212837146
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,22628,113,0.88 [0.55-1.41],0.6029082278067238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,22152,109,0.59 [0.33-1.05],0.0745629068114296
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,22670,116,0.60 [0.31-1.15],0.1231032231790692
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,22868,115,0.56 [0.26-1.18],0.1262237664843531
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,22670,116,1.20 [1.03-1.40],0.0187524085517623
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,22628,113,1.01 [0.83-1.23],0.9105880275031488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,19627,96,1.05 [0.87-1.27],0.6234453204408036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,22827,114,1.09 [0.69-1.70],0.7190407058155079
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,22918,116,0.98 [0.76-1.28],0.90849404684041
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,19233,94,1.30 [0.70-2.40],0.4015375889028211
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,19133,94,0.99 [0.68-1.44],0.9582553871711388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,19596,95,0.93 [0.74-1.17],0.5322065571755464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],22564,113,0.87 [0.65-1.18],0.3785133097491177
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,22679,117,1.10 [0.81-1.50],0.5388564230100937
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,19188,99,1.08 [0.85-1.36],0.5358736096261134
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,19133,94,1.00 [0.55-1.81],0.9963763472361488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,19133,94,1.13 [0.67-1.89],0.648298453487201
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,22105,111,1.08 [0.69-1.69],0.7359332009150515
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,19188,99,1.03 [0.55-1.96],0.915807532494344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,22442,108,0.91 [0.70-1.19],0.4980769064810021
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,19702,96,1.36 [0.89-2.08],0.1580722871670719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,22075,111,1.09 [0.82-1.45],0.5701671472158363
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,19353,94,1.20 [0.95-1.54],0.1318815307539997
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,19632,95,0.91 [0.68-1.20],0.4931883619343274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,22564,113,1.08 [0.65-1.79],0.7721249884711783
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,22679,117,1.53 [1.04-2.24],0.0294319213865614
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,19353,94,0.85 [0.59-1.20],0.3508387183338924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,18596,94,1.02 [0.86-1.20],0.842792758347943
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,22451,115,0.99 [0.75-1.31],0.9473576361515358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,22774,117,0.80 [0.56-1.14],0.2237227431567389
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,22564,113,0.80 [0.61-1.03],0.0870450243091302
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,19124,93,0.71 [0.45-1.13],0.1525494348957851
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,19693,96,0.95 [0.79-1.14],0.5829890529981622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,19233,94,1.09 [0.82-1.46],0.5333739817151626
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,22564,113,0.74 [0.50-1.10],0.1384103737327179
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,19696,99,1.04 [0.39-2.74],0.9412997554223866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,19693,96,0.99 [0.62-1.59],0.9659475738062616
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,22706,116,1.17 [0.71-1.91],0.5411720804664342
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,22525,113,1.07 [0.85-1.35],0.5712012194779745
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,22777,118,0.74 [0.34-1.61],0.4471480456452833
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,19186,95,0.81 [0.47-1.39],0.4459414818744246
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,19124,93,1.43 [1.13-1.81],0.0030869613444424
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,19632,95,0.85 [0.61-1.20],0.3563330993231042
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,19702,96,0.97 [0.71-1.33],0.8670185421160626
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",19233,94,0.98 [0.73-1.31],0.8808262670055423
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,22868,115,0.96 [0.85-1.09],0.5266065191488785
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,22555,116,0.68 [0.44-1.06],0.088596839068346
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,19133,94,0.85 [0.61-1.19],0.3527629862854892
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,22241,113,1.23 [0.97-1.54],0.0827337636999861
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,22075,111,0.83 [0.64-1.08],0.1618637208430192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,22514,109,1.06 [0.91-1.25],0.4413559293210309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,19702,96,1.02 [0.87-1.20],0.7695931412129355
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",19353,94,0.85 [0.56-1.30],0.4589700586302135
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,22266,114,1.03 [0.77-1.39],0.8450568562913988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,19233,94,1.06 [0.69-1.63],0.780422219466273
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,19002,95,0.97 [0.66-1.42],0.8584402732498115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,22105,111,0.86 [0.64-1.15],0.3142320580874502
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,19188,99,1.82 [1.43-2.32],1.042914560097227e-06
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,19528,94,0.97 [0.49-1.93],0.9417554696177476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,19693,96,1.09 [0.64-1.85],0.7494993264847818
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,19133,94,1.04 [0.80-1.34],0.7859428789352306
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,22810,115,0.85 [0.48-1.49],0.5656587947129563
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,22679,117,0.69 [0.38-1.26],0.228356306558519
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,22241,113,0.68 [0.47-0.98],0.0372465453078376
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,19353,94,0.96 [0.73-1.26],0.7714755762432031
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,22679,117,1.01 [0.75-1.37],0.9387335872515744
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,22628,113,0.99 [0.73-1.33],0.9300836378309292
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,19322,96,1.39 [0.93-2.06],0.1088328776076788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,19040,95,1.38 [0.73-2.61],0.3208444238097085
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,22105,111,1.09 [0.78-1.52],0.626950086069653
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,19632,95,1.26 [0.70-2.29],0.4416756219518255
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,19124,93,1.13 [0.94-1.37],0.1935966551350162
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19283,96,1.05 [0.69-1.61],0.8233635961137062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,19702,96,1.05 [0.80-1.37],0.7509953615408468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,22848,116,1.00 [0.47-2.14],0.9905157169422056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,19702,96,1.59 [0.77-3.26],0.2077437368712502
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,22670,116,1.40 [0.88-2.23],0.1494355884266663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,19632,95,0.89 [0.49-1.63],0.7160902422347897
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,19632,95,1.06 [0.59-1.90],0.8407127637911387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,19627,96,0.95 [0.58-1.56],0.8367213324397544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,19040,95,1.06 [0.80-1.42],0.6832898573412867
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,19627,96,0.95 [0.61-1.47],0.8078441592712597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,22941,117,0.86 [0.57-1.31],0.4895216089135508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,19632,95,0.97 [0.75-1.26],0.8322083231140964
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,19732,96,0.95 [0.78-1.16],0.6400523412287
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,22836,114,0.93 [0.63-1.38],0.7281059872033917
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,22564,113,1.64 [0.98-2.76],0.060183048957998
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,22868,115,0.97 [0.73-1.29],0.8497804895374286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,22670,116,0.83 [0.69-1.00],0.050665498839207
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,19040,95,1.11 [0.80-1.53],0.5315441692537142
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",19040,95,0.79 [0.51-1.23],0.2992435444228247
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",19133,94,1.11 [0.84-1.48],0.4615019506309601
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",19322,96,1.02 [0.84-1.23],0.8388548905747023
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,22941,117,1.05 [0.84-1.31],0.6636596878855487
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,22774,117,0.95 [0.79-1.14],0.5755620614904824
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,22152,109,1.20 [0.69-2.10],0.5166672773036145
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,22670,116,1.25 [0.71-2.22],0.4347829528141523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,22941,117,1.23 [0.76-1.97],0.4005290627647301
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,19040,95,1.09 [0.68-1.73],0.7227614530899094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,19322,96,1.50 [0.86-2.63],0.1537383273937125
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,19730,98,0.94 [0.68-1.29],0.6845168042493315
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,19040,95,1.06 [0.77-1.44],0.7270673456916122
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,19702,96,0.97 [0.82-1.14],0.6741694810525377
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,22774,117,0.98 [0.86-1.12],0.8013267802027395
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",22152,109,1.17 [0.87-1.57],0.3131261540796504
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,19186,95,0.97 [0.67-1.41],0.8829348678823863
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,19040,95,1.06 [0.79-1.42],0.7101581078985366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,19133,94,0.95 [0.67-1.33],0.7594356371558388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19188,99,1.87 [1.37-2.54],7.219903826311606e-05
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,22941,117,1.22 [0.59-2.54],0.5893655298521495
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,22679,117,1.04 [0.79-1.37],0.7962374524520238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,22679,117,0.73 [0.42-1.27],0.2605983813410196
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,19233,94,0.56 [0.26-1.22],0.1452862735538632
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,19322,96,0.95 [0.50-1.81],0.8870078134015935
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,19739,99,1.18 [0.57-2.46],0.651803967562508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,19188,99,1.19 [1.02-1.39],0.0255181665659421
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,19622,98,1.00 [0.82-1.21],0.9794711133655613
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,22105,111,0.98 [0.72-1.33],0.9092141305418906
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,19040,95,0.78 [0.52-1.19],0.2542375525689079
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,19186,95,1.18 [0.92-1.50],0.1905238920439891
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",22523,112,0.96 [0.77-1.19],0.7054090613988886
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,19739,99,1.00 [0.77-1.30],0.9974328205450196
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",19732,96,1.05 [0.73-1.49],0.8061642715626709
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,22918,116,1.34 [0.70-2.55],0.3763965871229905
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,22833,116,1.03 [0.70-1.52],0.8903841048106538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19506,99,0.72 [0.39-1.31],0.280062459866308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,19133,94,1.23 [0.95-1.59],0.1090719478666704
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,19186,95,0.95 [0.67-1.36],0.7868009489155388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,19188,99,1.04 [0.87-1.25],0.6401148442339775
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,19702,96,0.94 [0.79-1.12],0.4969750468846428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,19632,95,1.14 [0.79-1.64],0.4847765848472363
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,19040,95,0.96 [0.77-1.19],0.717849964487494
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22514,109,1.32 [0.73-2.37],0.3541782523834247
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,19322,96,1.23 [0.76-1.98],0.4044691804678002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,19739,99,1.40 [0.65-3.02],0.3846274641346807
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PI3,Elafin,22370,114,1.32 [1.01-1.73],0.0453808842802836
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",19702,96,0.88 [0.68-1.14],0.331917144290195
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,22390,115,1.75 [1.11-2.74],0.0151506413374826
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,22628,113,0.91 [0.69-1.19],0.4875193301721107
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22679,117,1.78 [0.99-3.21],0.0532954082783861
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,19188,99,1.04 [0.74-1.45],0.8392104893487348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,22679,117,1.13 [0.77-1.68],0.5256644742707646
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,22670,116,1.01 [0.76-1.35],0.9215797367628596
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,19322,96,1.02 [0.76-1.36],0.9090391602661204
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,19002,95,0.82 [0.61-1.09],0.1763806608721967
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,19732,96,1.29 [0.61-2.75],0.5076817244453526
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,19133,94,0.86 [0.60-1.23],0.3981320108927962
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,22700,116,0.84 [0.65-1.08],0.1658501042226029
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,19353,94,0.73 [0.55-0.97],0.0304441057066894
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,22514,109,1.31 [0.98-1.74],0.0662550216193753
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,22740,117,0.81 [0.43-1.54],0.524456587801603
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,22903,117,0.86 [0.59-1.26],0.4491007959074383
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",22595,115,1.26 [0.99-1.60],0.0563386538364988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,22774,117,1.05 [0.87-1.27],0.6030795843482036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,22679,117,0.57 [0.35-0.94],0.026220963961528
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,22873,117,0.92 [0.66-1.27],0.6088512780917936
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,22679,117,0.89 [0.50-1.57],0.6838340372787659
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,22521,115,1.50 [0.83-2.73],0.1827878551769064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",19693,96,0.80 [0.59-1.10],0.1721085133061732
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",19188,99,0.93 [0.59-1.46],0.747748435412934
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",19693,96,0.97 [0.79-1.18],0.7477689852335427
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,19693,96,0.95 [0.72-1.27],0.7433902896291541
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,19245,97,0.49 [0.21-1.15],0.1012043777258335
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,22105,111,0.54 [0.31-0.94],0.0309535447893274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,22670,116,1.10 [0.76-1.60],0.6131316252079688
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,22670,116,0.97 [0.77-1.24],0.8311441342225778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,19663,96,0.85 [0.61-1.18],0.3318734213908609
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,22852,115,0.83 [0.52-1.33],0.4435120558405127
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,22152,109,0.74 [0.41-1.33],0.3174185169833735
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,19693,96,1.44 [0.80-2.59],0.220851057436428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,22628,113,0.92 [0.75-1.13],0.4271476963231785
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,22839,116,1.45 [0.73-2.90],0.2874450589242707
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,22604,116,1.06 [0.75-1.51],0.7383469543011973
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,22564,115,0.97 [0.89-1.07],0.542527011449561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,19133,94,1.05 [0.85-1.30],0.6469721009692094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,19133,94,1.14 [0.83-1.58],0.4161740499592417
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,19186,95,0.84 [0.55-1.27],0.4123350260413473
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,22066,111,0.98 [0.84-1.14],0.8253851868997995
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,19739,99,0.98 [0.72-1.33],0.8850500667885698
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,19693,96,1.26 [0.98-1.61],0.0722603436640871
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,22663,115,1.00 [0.95-1.06],0.9946585742402784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,19233,94,0.96 [0.67-1.37],0.8094191401500236
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,19124,93,0.77 [0.47-1.25],0.2911683271895669
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",22241,113,1.09 [0.96-1.25],0.1737966837049474
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,22564,113,1.03 [0.35-3.06],0.9548833999484796
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,22740,117,1.02 [0.56-1.85],0.9399650454997946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,19188,99,1.11 [0.74-1.66],0.6227908014452077
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,19188,99,1.14 [0.60-2.15],0.6924083715310005
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",22564,113,0.94 [0.56-1.57],0.8055569550316943
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,19233,94,0.93 [0.69-1.25],0.6216425149596654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,19739,99,0.99 [0.48-2.06],0.9828150841381372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,22266,114,1.01 [0.62-1.63],0.9822035177585656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,22774,117,1.46 [0.75-2.82],0.2613510028866699
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,19730,98,0.66 [0.39-1.12],0.1262487077197625
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,19619,99,1.02 [0.81-1.28],0.8600740739913649
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,22868,115,0.89 [0.62-1.26],0.4983654667757596
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,22676,114,1.03 [0.86-1.22],0.7717541994282076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,19353,94,1.08 [0.81-1.43],0.5957715258866636
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",19730,98,1.04 [0.77-1.40],0.8110606490301359
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,19188,99,1.30 [0.77-2.21],0.3284824482288956
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,22152,109,1.12 [0.67-1.87],0.670217276035495
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,19188,99,1.15 [0.88-1.50],0.3079806203507491
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,19732,96,0.96 [0.66-1.40],0.8235372062099281
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,22564,113,0.85 [0.65-1.11],0.2234447759019695
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,19627,96,0.95 [0.75-1.21],0.6709321605197083
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,22740,117,0.92 [0.78-1.10],0.3587829173779352
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,19353,94,0.95 [0.72-1.26],0.7393691204826978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,19702,96,0.89 [0.69-1.15],0.3768251080644467
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,19702,96,1.27 [0.80-2.01],0.3067502499041483
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,22670,116,0.97 [0.79-1.20],0.7991854961192877
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,22918,116,0.95 [0.80-1.14],0.6006403629848106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,19632,95,0.97 [0.82-1.15],0.7098705701335246
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,22514,109,0.74 [0.49-1.12],0.1533238574692028
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,19186,95,0.99 [0.76-1.28],0.9300668695710108
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,22656,115,1.03 [0.88-1.21],0.701900710282486
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,22152,109,1.13 [0.86-1.49],0.362412868369561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,19040,95,1.53 [0.75-3.12],0.2419108437080329
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,19730,98,1.20 [0.75-1.90],0.450092820619854
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,19627,96,0.87 [0.53-1.44],0.5964573423171737
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,22809,117,1.28 [0.78-2.11],0.3295691514047416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,22047,106,0.94 [0.77-1.15],0.5501163777675918
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,19398,97,1.05 [0.78-1.41],0.75814993713612
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",22241,113,0.94 [0.75-1.19],0.626173530771455
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",22918,116,1.01 [0.79-1.28],0.9376291650935886
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,22868,114,0.83 [0.63-1.10],0.1896435032412451
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,22241,113,0.84 [0.47-1.51],0.5669469583238157
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,22663,115,0.90 [0.45-1.81],0.7736187897929039
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,19730,98,0.78 [0.53-1.14],0.1963560886493116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,19730,98,0.51 [0.35-0.73],0.0002952745705283
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,22241,113,0.96 [0.70-1.32],0.8012958828993207
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19186,95,0.58 [0.28-1.17],0.1284546422865628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,22670,116,0.91 [0.75-1.10],0.3368118415970949
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,19657,96,0.89 [0.71-1.13],0.3334668379710888
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,22241,113,1.05 [0.73-1.52],0.7876801560428535
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,19133,94,0.84 [0.52-1.33],0.4505035345926563
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,19322,96,0.99 [0.84-1.15],0.8560614684710692
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,22152,109,0.98 [0.76-1.27],0.869254806124655
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,22868,115,0.91 [0.72-1.14],0.4170084217023484
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,19693,96,1.12 [0.78-1.61],0.5284432402319844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,22697,118,1.29 [0.66-2.51],0.4581152173409943
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,19133,94,0.96 [0.55-1.68],0.8881874302207677
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,22628,113,0.91 [0.69-1.20],0.5097946855624591
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,19764,99,0.85 [0.39-1.88],0.695859673753016
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,19184,96,1.13 [0.86-1.49],0.3937598015164844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,19188,99,1.16 [0.79-1.70],0.4433698123197653
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,19233,94,1.03 [0.61-1.74],0.9236582259860566
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,22734,118,1.23 [0.91-1.68],0.1797602927144786
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,19188,99,1.32 [0.88-1.99],0.1764522243184953
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,22603,116,1.05 [0.70-1.59],0.807237241242635
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,19693,96,1.63 [0.97-2.74],0.0637428568528268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,22590,117,1.48 [1.01-2.18],0.0449875712013654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,22105,111,0.97 [0.83-1.12],0.6528306690816027
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,22868,114,0.71 [0.36-1.38],0.3121338869345967
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,22080,112,1.03 [0.73-1.45],0.8701903697473305
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,19353,94,1.12 [0.60-2.11],0.7166114457936409
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,19540,98,1.48 [0.84-2.61],0.1709275501194244
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,19632,95,0.87 [0.58-1.29],0.475086111165772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,19632,95,1.02 [0.94-1.10],0.6570081873489233
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,22514,109,0.95 [0.83-1.08],0.4265041071016316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,22628,113,0.90 [0.68-1.20],0.4672617455078663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,22152,109,1.02 [0.71-1.48],0.8964044646643352
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,19040,95,0.69 [0.36-1.35],0.2801857024386484
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,19702,96,0.82 [0.54-1.23],0.3312748051780942
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,19186,95,1.03 [0.74-1.44],0.8407092592541044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,22564,113,0.70 [0.51-0.97],0.032597516274124
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,22484,109,1.00 [0.64-1.56],0.9958054216487032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,22399,106,1.11 [0.70-1.75],0.6655431059493473
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,22628,113,0.96 [0.70-1.33],0.8190579774698432
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,19188,99,1.00 [0.71-1.39],0.9802323627984986
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,22628,113,1.01 [0.85-1.19],0.9314113124113794
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,22152,109,1.19 [0.90-1.56],0.2206500142859598
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,18632,93,1.02 [0.84-1.23],0.8296164963938996
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",22105,111,0.76 [0.44-1.33],0.3414251606639942
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,22474,117,1.50 [0.90-2.53],0.1220401723625688
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,19038,99,1.16 [0.82-1.65],0.4045097997985595
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,19732,96,1.13 [0.89-1.43],0.3127680131633543
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,19186,95,0.96 [0.75-1.24],0.7744142675376492
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,22628,113,1.11 [0.75-1.64],0.5990052492998857
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,22105,111,0.97 [0.62-1.53],0.9077309447833332
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,22266,114,1.36 [0.99-1.88],0.0573323835867552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,19188,99,1.03 [0.73-1.45],0.880352568856131
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,22514,109,0.94 [0.75-1.17],0.5582619636671333
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,22734,116,1.02 [0.84-1.22],0.8697603895512975
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,19149,98,0.97 [0.56-1.67],0.9029059055534464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,19732,96,0.97 [0.49-1.92],0.9322062485597264
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,19730,98,0.88 [0.37-2.09],0.7671009763640972
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,22941,117,0.77 [0.44-1.34],0.3496443784407406
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,19632,95,1.06 [0.70-1.59],0.7936015819897331
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,19632,95,1.33 [0.61-2.93],0.4742969167030603
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,22591,113,1.08 [0.54-2.14],0.835679964696205
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,22433,107,1.23 [0.73-2.08],0.4433927913501488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,19693,96,0.85 [0.49-1.49],0.5797083940499224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,22941,117,1.17 [0.60-2.30],0.6458259183099999
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,19732,96,1.25 [0.69-2.25],0.4666591641712156
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,19322,96,1.06 [0.77-1.46],0.7388575241370727
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,22014,110,1.05 [0.77-1.43],0.7393235619053985
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,19353,94,0.69 [0.41-1.17],0.170488758396574
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,22628,113,1.09 [0.76-1.54],0.6468039941464936
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,22756,114,0.97 [0.84-1.12],0.661898957508904
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,22868,115,1.65 [1.09-2.50],0.0181307544262404
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,19627,96,0.95 [0.65-1.37],0.768407355776529
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,22105,111,0.96 [0.69-1.34],0.8126301991152983
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,19233,94,1.61 [1.20-2.17],0.0016325121598098
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,19133,94,1.30 [1.08-1.57],0.005932787032648
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,19764,99,0.93 [0.69-1.27],0.6662715565768116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,22570,115,0.97 [0.67-1.42],0.8832652909923266
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,22712,117,0.70 [0.38-1.29],0.2580032666329738
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,19358,97,1.04 [0.68-1.62],0.8444264530756521
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,19732,96,0.83 [0.57-1.20],0.3197915077105657
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,19732,96,0.91 [0.76-1.09],0.321471861538435
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,19732,96,0.96 [0.76-1.22],0.7419351131533114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,19627,96,0.90 [0.65-1.25],0.5475358406265171
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,19133,94,1.07 [0.80-1.44],0.6473534200984521
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,22241,113,1.10 [0.90-1.33],0.3526668385823949
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,19133,94,0.90 [0.69-1.18],0.4341997620137605
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,19124,93,0.75 [0.49-1.16],0.1947267601436622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,19627,96,0.76 [0.44-1.30],0.3135171997475816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,22628,113,0.63 [0.44-0.90],0.0115241506931165
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,22105,111,1.28 [0.96-1.71],0.0893074646528746
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,19322,96,0.97 [0.76-1.25],0.8149739261393123
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,22152,109,1.16 [0.89-1.52],0.2627744173065609
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,22241,113,0.92 [0.69-1.21],0.5467551188276549
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,19186,95,0.78 [0.54-1.12],0.1723550162552761
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,22152,109,0.88 [0.61-1.29],0.5184794685214749
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,19353,94,1.08 [0.79-1.49],0.6250977469736616
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,19188,99,1.06 [0.56-2.01],0.8487226736556245
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,19627,96,0.90 [0.59-1.37],0.6252417278340137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,19233,94,0.81 [0.56-1.18],0.2696822432571032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,19124,93,0.85 [0.46-1.58],0.6155671026242837
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,22152,109,1.11 [0.80-1.55],0.5178718109237381
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,19188,99,0.93 [0.69-1.27],0.6640738509883055
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,19353,94,0.90 [0.61-1.32],0.5765585219039697
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,22152,109,1.28 [0.84-1.93],0.2479221242114503
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,22777,118,1.22 [0.87-1.70],0.251140887022434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,22105,111,1.08 [0.66-1.76],0.7556010641331767
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,19040,95,1.00 [0.64-1.56],0.9935291054051798
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,22152,109,0.96 [0.70-1.31],0.8081111899900743
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,19702,96,1.31 [0.81-2.11],0.271208738356801
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,22123,107,0.85 [0.61-1.18],0.3174443515313094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,19702,96,0.97 [0.75-1.25],0.8049229556803088
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,19133,94,1.21 [0.84-1.73],0.3033201990392924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,19040,95,1.05 [0.69-1.59],0.8322590876371905
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,19186,95,1.04 [0.80-1.36],0.7756340507499315
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,22564,113,1.14 [0.92-1.41],0.2430918852687397
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,22564,113,0.93 [0.69-1.27],0.6545552729892484
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,19632,95,0.94 [0.67-1.32],0.7269846973256909
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,19188,99,1.17 [0.92-1.47],0.1939899641422584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,19233,94,0.86 [0.71-1.05],0.1403676866417661
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,19627,96,0.92 [0.62-1.37],0.6804410829131853
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,22266,114,1.11 [0.80-1.55],0.5229168087572655
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,19233,94,0.86 [0.31-2.33],0.7617838478903385
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,19702,96,0.93 [0.67-1.28],0.6408323250904171
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,22513,117,1.23 [0.91-1.68],0.1781897890087607
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,22941,117,1.24 [0.96-1.61],0.1049147481856078
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,22941,117,1.22 [0.95-1.56],0.1196758166773113
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,19627,96,0.83 [0.50-1.37],0.4673327323333424
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,22706,116,0.90 [0.64-1.27],0.555349789964682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,19188,99,1.23 [0.90-1.68],0.2036783755441666
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,22679,117,1.81 [1.03-3.19],0.0381706613207765
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REN,Renin,22670,116,1.14 [0.92-1.40],0.2339196188272601
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,19188,99,1.05 [0.64-1.72],0.843259700346842
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,19040,95,1.41 [0.89-2.23],0.1384082130005993
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,22564,113,0.95 [0.63-1.42],0.7878781779355502
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RETN,Resistin,22602,115,1.00 [0.67-1.50],0.99976576595305
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",19133,94,0.86 [0.55-1.33],0.4931314609447168
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,19627,96,0.43 [0.15-1.18],0.0994633662764249
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,19702,96,0.86 [0.66-1.11],0.2361943112618277
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,19353,94,1.15 [0.88-1.49],0.2959818219851527
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,22868,115,0.93 [0.54-1.58],0.7761093845966849
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,22868,115,0.94 [0.50-1.78],0.8496231995896888
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,19702,96,0.96 [0.69-1.34],0.8298755677438614
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,22241,113,1.23 [1.01-1.50],0.0361468429251103
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,22358,109,0.97 [0.84-1.12],0.6707862609717995
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,19188,99,1.06 [0.73-1.54],0.7450575825258898
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19322,96,1.05 [0.71-1.56],0.7962356248434858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,22796,114,0.93 [0.71-1.22],0.6053409600006112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,19732,96,0.97 [0.79-1.18],0.7510408657836214
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,19133,94,1.08 [0.84-1.39],0.5308029441348063
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,19702,96,0.85 [0.58-1.25],0.4195469943834858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,19285,95,0.92 [0.72-1.16],0.4701644053557845
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,19739,99,2.03 [1.21-3.39],0.0070187663237437
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,19233,94,1.11 [0.75-1.64],0.5991435604769577
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,22568,116,0.91 [0.77-1.06],0.2199637645951749
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,19070,96,2.14 [1.26-3.62],0.004589492273184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,19584,99,1.44 [0.91-2.30],0.1232534515126571
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,19702,96,0.94 [0.62-1.41],0.7557124942018166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,22841,117,1.20 [0.67-2.15],0.5390502073656487
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,19233,94,1.66 [0.97-2.85],0.0652798467205086
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,19188,99,1.19 [0.76-1.84],0.4475600889505062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,19188,99,0.88 [0.50-1.56],0.6697523860100167
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,19353,94,1.37 [1.11-1.69],0.0033450804462553
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,22152,109,0.99 [0.77-1.27],0.9161014206206493
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,19353,94,1.12 [0.83-1.53],0.4551037403557281
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,19233,94,0.80 [0.62-1.05],0.1028281228885251
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,22706,116,0.93 [0.47-1.85],0.8374095829675092
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,22868,115,0.74 [0.37-1.50],0.4104340086192954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,19233,94,3.27 [1.09-9.82],0.0351841143263437
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,22670,116,1.00 [0.60-1.68],0.9963046854310146
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,22564,113,0.91 [0.61-1.37],0.6674030935904545
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,19188,99,1.44 [0.83-2.51],0.1917625836856258
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,19353,94,0.97 [0.73-1.28],0.8067946391779719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,19186,95,1.09 [0.70-1.70],0.6994387624257354
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,19233,94,1.17 [0.74-1.85],0.4971821487805863
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,19133,94,0.98 [0.60-1.57],0.9193413948424995
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,19186,95,0.96 [0.83-1.12],0.637768728661163
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,22152,109,1.17 [0.90-1.53],0.2428613205430707
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,22152,109,0.86 [0.67-1.12],0.2624940690944491
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,19124,93,0.92 [0.74-1.14],0.4465384719900072
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,22514,109,0.99 [0.60-1.64],0.9735731038500012
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,22868,114,1.28 [0.71-2.30],0.4094873228274523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,22564,113,1.10 [0.61-1.97],0.7479173952957234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,19133,94,1.22 [0.91-1.64],0.1889402070567819
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",19702,96,0.95 [0.77-1.18],0.6593259438611347
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,22868,114,0.73 [0.45-1.19],0.2061892850172511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,22152,109,0.99 [0.84-1.16],0.9093965128856774
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,22868,115,1.02 [0.79-1.32],0.861051553528479
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,19133,94,1.07 [0.62-1.86],0.8113850408090536
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,22490,116,0.96 [0.67-1.37],0.8284441442031147
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,22362,113,0.82 [0.65-1.02],0.0804526937044644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,19188,99,1.69 [1.11-2.59],0.0149632197536235
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,19702,96,0.75 [0.51-1.10],0.1404696329116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,22075,111,1.11 [0.85-1.43],0.4437934089622192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,19627,96,1.25 [0.91-1.72],0.1682514257809556
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,22740,117,0.81 [0.61-1.07],0.1373062279624692
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,19702,96,0.82 [0.52-1.29],0.3856571865752072
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,22266,114,0.98 [0.73-1.33],0.9117383781665068
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,19764,99,1.06 [0.59-1.90],0.83976299787488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,19702,96,0.67 [0.31-1.45],0.3111982559328756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,19124,93,0.99 [0.67-1.46],0.94939838887066
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,22628,113,0.99 [0.79-1.25],0.9396762577239784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,19353,94,1.03 [0.80-1.32],0.8387222796016295
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,19657,96,1.00 [0.84-1.20],0.9990872366932854
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,19133,94,0.85 [0.47-1.55],0.6012877258859293
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,19133,94,1.28 [0.94-1.75],0.1159808052073123
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,19353,94,1.09 [0.83-1.43],0.525022960945023
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,19702,96,1.13 [0.62-2.06],0.6986532120993291
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,19692,98,0.81 [0.45-1.45],0.4823168272714667
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,22564,113,0.98 [0.81-1.19],0.8643952571601032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,22868,115,1.59 [0.91-2.78],0.1054082168055025
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,22105,111,0.96 [0.71-1.30],0.7980314725534157
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,22091,108,2.19 [1.35-3.57],0.0015691163652738
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,22941,117,1.34 [0.92-1.96],0.1301284869621054
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,22868,115,1.69 [0.96-2.97],0.0684196385081459
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,22755,114,1.27 [0.76-2.13],0.3635822609574772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,22706,116,0.89 [0.55-1.45],0.6376897033591065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,22701,117,1.10 [0.82-1.47],0.5165799637439771
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,19133,94,1.06 [0.58-1.95],0.8529177949180129
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,19322,96,1.37 [0.63-2.98],0.4298872912701574
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,22734,116,1.05 [0.88-1.24],0.6161207146779633
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,22241,113,0.96 [0.65-1.40],0.8163320945833673
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,19124,93,0.98 [0.75-1.30],0.9132993582473689
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,22796,114,0.93 [0.65-1.33],0.6947988866699524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,19124,93,0.83 [0.52-1.32],0.4336953898871956
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,19186,95,0.67 [0.32-1.41],0.2919366182439394
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,19186,95,1.35 [0.89-2.03],0.1552624372989987
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,19124,93,0.87 [0.55-1.37],0.5465681155110569
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,19233,94,1.27 [0.79-2.03],0.3213597752733433
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,22152,109,1.04 [0.83-1.30],0.7203421187239569
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,19158,94,1.05 [0.70-1.58],0.7967495878093006
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,19732,96,1.85 [0.94-3.64],0.0745431706223097
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,19233,94,1.02 [0.83-1.26],0.8195352310132171
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,22628,113,0.93 [0.69-1.25],0.6193709705026207
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCT,Secretin,19186,95,0.82 [0.53-1.25],0.3500544083866362
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,22670,116,1.47 [1.00-2.17],0.0512252282317456
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,22670,116,0.93 [0.65-1.33],0.6946292766373541
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,19627,96,0.90 [0.76-1.07],0.2318220075534889
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,19632,95,0.96 [0.71-1.28],0.7621939282782368
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,19322,96,1.24 [0.77-2.01],0.3818688046457034
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,19233,94,0.90 [0.70-1.17],0.4451223492415963
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,19233,94,1.54 [1.03-2.29],0.0344833950357262
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,22941,117,1.17 [0.84-1.62],0.3546139477997618
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,19764,99,1.04 [0.45-2.43],0.9209798921111948
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,19764,99,0.33 [0.15-0.69],0.0034808930803537
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,22734,118,0.97 [0.73-1.28],0.8144848063166421
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,22628,113,1.14 [0.60-2.17],0.6840049195189841
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,22670,116,1.21 [0.64-2.28],0.5519382840751934
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,19322,96,1.14 [0.73-1.77],0.569537586871286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,22564,113,0.92 [0.49-1.70],0.7815724292496166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,22868,115,0.95 [0.55-1.64],0.8468800206534286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,19188,99,1.36 [0.73-2.51],0.3335243553081022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,22873,117,0.80 [0.42-1.50],0.4811093784897781
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,19702,96,1.03 [0.79-1.34],0.8283666972282819
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,19353,94,1.00 [0.69-1.45],0.9933928793609162
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,19652,96,1.35 [0.76-2.40],0.3130024407103572
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,22564,113,0.91 [0.50-1.66],0.7707166196888324
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,19375,97,5.24 [0.53-52.19],0.1577197728462403
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,22941,117,1.05 [0.70-1.57],0.8127503638076063
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,22025,114,1.05 [0.90-1.22],0.5488242959521612
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,19684,99,1.72 [0.50-5.87],0.3856354975962479
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,19385,97,0.59 [0.26-1.32],0.1998748969976121
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,19458,97,0.70 [0.37-1.33],0.2817450014241336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,19764,99,0.70 [0.22-2.25],0.5483821012089363
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,19764,99,0.94 [0.33-2.64],0.9001123703470778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,22433,113,0.93 [0.73-1.18],0.5326560024413263
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,22608,117,1.05 [0.88-1.26],0.583436569494324
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,22266,114,0.95 [0.68-1.32],0.7609116626498509
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,22796,114,1.08 [0.82-1.43],0.5769466757529244
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,22918,116,1.06 [0.81-1.39],0.6542061351505015
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,22514,109,0.93 [0.56-1.55],0.7850176976990979
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,19720,99,0.56 [0.15-2.02],0.3738821216701651
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,19720,99,0.95 [0.47-1.95],0.8955651668311407
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,22941,117,1.03 [0.81-1.31],0.8117007304267803
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,19732,96,0.98 [0.72-1.32],0.8778163876063506
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,19461,98,1.23 [0.59-2.54],0.5835184934157681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,19385,98,1.43 [0.35-5.96],0.6199795402882674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,19720,99,1.41 [0.49-4.03],0.5193042432013781
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,19353,94,1.00 [0.86-1.16],0.9870807193098128
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,19279,96,1.43 [0.81-2.52],0.2192029196381272
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,19632,95,1.09 [0.77-1.54],0.6286074481120084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,22105,111,1.03 [0.80-1.34],0.8157638291012718
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,22452,109,0.72 [0.40-1.33],0.295732171583509
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,19186,95,1.64 [0.93-2.89],0.0876950160001893
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,22740,117,0.74 [0.40-1.36],0.3341493575752519
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,22564,113,0.82 [0.40-1.69],0.5872510385759595
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,22564,113,0.90 [0.72-1.13],0.3671798829410746
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,22447,108,1.00 [0.67-1.49],0.9990356185519584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,19322,96,1.04 [0.64-1.70],0.8664546012612215
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,22152,109,1.11 [0.86-1.44],0.4230705673315735
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,22152,109,0.95 [0.68-1.33],0.7571059358667238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,22670,116,1.08 [0.85-1.39],0.521927794331303
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,19379,95,1.21 [0.87-1.68],0.2600254922423676
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,22152,109,0.99 [0.83-1.18],0.9010846029182265
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,22628,113,0.81 [0.58-1.13],0.2111210243023118
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,19124,93,0.82 [0.56-1.21],0.3238479257454818
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,19632,95,0.92 [0.60-1.39],0.681611730631644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,19248,94,0.96 [0.76-1.21],0.7390699082577615
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,19693,96,0.92 [0.69-1.22],0.557235257427008
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,19739,99,0.87 [0.61-1.25],0.4588361726393207
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,19040,95,1.13 [0.97-1.32],0.122935057585489
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,19094,94,0.90 [0.69-1.16],0.401804340741943
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,19188,99,1.08 [0.69-1.68],0.7338960982007214
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,19730,98,2.03 [1.21-3.40],0.0075223889641812
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",22734,116,1.02 [0.84-1.23],0.834786392277482
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,19353,94,0.96 [0.59-1.55],0.8683161137851444
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,22704,117,1.03 [0.72-1.46],0.8759748523601597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,22774,117,1.34 [0.92-1.95],0.1293198173080308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,22628,113,1.72 [1.05-2.82],0.0318952993760052
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,22105,111,0.76 [0.58-1.00],0.0532884889839954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,22679,117,1.17 [0.98-1.38],0.0744669202492517
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,22868,114,0.80 [0.48-1.31],0.3692841574356911
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,22670,116,0.89 [0.49-1.61],0.7041255898072629
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,19233,94,1.11 [0.71-1.73],0.6539642234137844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,22835,114,0.68 [0.38-1.19],0.1764678708527002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,19233,94,1.25 [0.75-2.09],0.389412007982841
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,22718,113,0.71 [0.55-0.93],0.0115282918525192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,22629,115,1.04 [0.72-1.49],0.8424479016162967
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,19188,99,1.13 [0.93-1.37],0.2146416757831242
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,22564,113,0.95 [0.79-1.14],0.5768711016123184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",22105,111,0.93 [0.68-1.27],0.6517779005206665
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,22241,113,0.92 [0.68-1.24],0.5686794401343684
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,22465,108,0.87 [0.69-1.10],0.2502303402942034
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,22774,117,0.96 [0.82-1.12],0.5810726339681515
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,19133,94,1.30 [0.88-1.92],0.1808271953909637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,19702,96,0.99 [0.82-1.20],0.9199866079241787
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,22241,113,1.37 [1.02-1.84],0.0349465366625439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,22152,109,1.11 [0.70-1.75],0.6671193090344999
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,22628,113,0.85 [0.63-1.13],0.2623633262395505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,22152,109,1.16 [0.85-1.60],0.3521608663001495
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,19133,94,1.01 [0.48-2.09],0.9879736733282776
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,19627,96,0.97 [0.69-1.35],0.8381301533539862
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,22105,111,1.08 [0.83-1.42],0.5567189645236241
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,19186,95,1.07 [0.75-1.53],0.7198024056166501
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,22105,111,1.01 [0.78-1.30],0.9478255955280636
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,19040,95,1.27 [0.99-1.64],0.0624661071184877
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,19040,95,1.47 [1.14-1.90],0.0027439430771292
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,22105,111,1.53 [1.04-2.26],0.0327585045965314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,22628,113,1.02 [0.75-1.38],0.9205316717153502
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,19186,95,1.01 [0.77-1.33],0.9238873451745284
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,19730,98,0.82 [0.54-1.24],0.3389497738610736
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,19133,94,0.67 [0.50-0.91],0.0095397414606173
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,19322,96,1.09 [0.86-1.37],0.4805922955673325
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,19632,95,0.91 [0.60-1.40],0.6817777090509303
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",19040,95,1.17 [0.86-1.59],0.3164698653038677
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,22105,111,0.98 [0.70-1.36],0.8940223258656923
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,19188,99,0.80 [0.44-1.48],0.4809153280585027
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,22868,114,1.00 [0.65-1.55],0.989550305682712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,22266,114,1.07 [0.66-1.73],0.7906865479438019
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,19353,94,0.82 [0.60-1.13],0.2230599230229394
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,19632,95,0.91 [0.71-1.16],0.4339596521775158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,19576,98,0.97 [0.58-1.61],0.8978704238846534
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,22152,109,0.98 [0.79-1.21],0.8244523201690171
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,19627,96,0.98 [0.73-1.30],0.8673827739287152
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,19627,96,0.88 [0.60-1.31],0.5390876101012068
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,22564,113,0.94 [0.41-2.14],0.8796980577788199
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,22105,111,1.01 [0.80-1.29],0.9042781255240712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,19040,95,0.76 [0.50-1.15],0.1964471610019378
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,19632,95,0.86 [0.60-1.23],0.4054418839272335
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,22868,114,1.53 [0.94-2.51],0.0894683623052609
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,22774,117,1.07 [0.69-1.65],0.7748452586089567
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,22753,113,1.38 [0.99-1.93],0.0605206419934997
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,19188,99,1.02 [0.73-1.43],0.904414036810226
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,22740,117,1.28 [0.98-1.67],0.0647638937921511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,19627,96,0.91 [0.69-1.21],0.5090124454365788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,19124,93,0.94 [0.68-1.29],0.6898455679213628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,19661,96,0.85 [0.68-1.06],0.142110207678174
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,22670,116,0.96 [0.80-1.16],0.6753068692753312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,19124,93,0.90 [0.59-1.38],0.6229404714907085
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,22740,117,0.94 [0.79-1.12],0.5031003480875427
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,19702,96,0.97 [0.69-1.37],0.8771539560287344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,19322,96,0.99 [0.84-1.18],0.935735036738264
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,22514,109,1.07 [0.83-1.38],0.5910697153413222
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",19233,94,1.14 [0.64-2.01],0.6552020553519998
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',19693,96,1.06 [0.70-1.61],0.7730818495684628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,19133,94,1.08 [0.81-1.45],0.6041937243035663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,19322,96,1.03 [0.72-1.48],0.856677297698798
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,19632,95,0.99 [0.63-1.55],0.9572087283683256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,19627,96,0.90 [0.69-1.16],0.4071210862467995
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,19233,94,0.59 [0.28-1.22],0.1514726396001618
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,22670,116,1.08 [0.85-1.37],0.5287923091365854
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],22190,117,0.95 [0.68-1.34],0.7884352536875678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",22679,117,1.40 [0.94-2.09],0.1010035026722307
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,19739,99,0.88 [0.60-1.28],0.4884648845287581
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,19702,96,0.99 [0.60-1.61],0.956397865284344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,22152,109,1.52 [0.95-2.43],0.0832731602763413
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,22759,114,1.00 [0.78-1.29],0.9786939370819024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,22636,116,1.07 [0.68-1.67],0.76970372555516
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,22636,116,1.30 [0.85-1.99],0.222220977070606
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,19186,95,0.89 [0.58-1.35],0.578654785466258
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,19674,95,0.93 [0.40-2.16],0.861163308618991
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,19186,95,0.80 [0.39-1.66],0.5489807279108735
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,19702,96,1.20 [0.65-2.22],0.5615221605973042
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,19702,96,1.17 [0.86-1.59],0.3247476532228276
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,22740,117,0.93 [0.75-1.17],0.5570624202551722
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,22661,118,0.50 [0.28-0.89],0.0193766408838151
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPART,Spartin,19322,96,1.01 [0.78-1.30],0.9637009383422166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,19732,96,1.61 [0.84-3.09],0.1486174794045295
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,22679,117,1.66 [1.19-2.32],0.0031002355753902
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,19322,96,0.87 [0.51-1.47],0.5969193879866646
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,22628,113,1.15 [0.90-1.46],0.2757382885243175
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,22679,117,1.21 [0.73-2.01],0.453475128496385
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,22868,114,1.17 [0.85-1.60],0.3275382108556773
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,19133,94,0.83 [0.46-1.49],0.5335894913535388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,22615,117,1.01 [0.51-1.99],0.98400132424267
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,22774,117,1.20 [0.81-1.80],0.3619499475092075
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,19632,95,0.99 [0.85-1.15],0.8582517148546821
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,22514,109,0.61 [0.31-1.21],0.158216234033762
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,22706,116,1.23 [0.74-2.05],0.4211507815581977
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,22570,116,1.35 [0.85-2.14],0.2077760461536323
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,22901,116,1.30 [0.92-1.84],0.1370758004075757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",19188,99,1.14 [0.75-1.74],0.5315367549799473
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,19040,95,1.08 [0.80-1.47],0.612470124123274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,19353,94,1.10 [0.89-1.36],0.3929401399675267
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,19693,96,1.08 [0.82-1.41],0.5932640660374291
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,22241,113,0.97 [0.80-1.16],0.7129459428640671
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",19124,93,1.30 [0.77-2.20],0.3310256029144746
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,19693,96,0.91 [0.52-1.60],0.7365037181761185
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,22700,117,0.96 [0.84-1.10],0.5580013768070089
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,22564,113,0.92 [0.70-1.22],0.5589179436852691
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,22628,113,0.92 [0.75-1.13],0.4364511703494017
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,19732,96,1.47 [0.81-2.66],0.2049427021084747
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,22105,111,0.87 [0.63-1.21],0.4126192943726363
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",19188,99,0.96 [0.55-1.67],0.8721403386999685
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,22636,116,1.02 [0.87-1.20],0.7712822432506854
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,22734,118,1.09 [0.73-1.60],0.6815473563849874
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,19040,95,1.71 [1.02-2.86],0.0406975128708669
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,19632,95,1.04 [0.72-1.51],0.8275866412316577
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,19322,96,1.03 [0.73-1.46],0.8481279422993455
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",22564,113,1.14 [0.77-1.69],0.5047584386110147
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",22941,117,1.29 [0.74-2.25],0.3694777502689136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",19188,99,1.27 [0.92-1.76],0.1446071805314005
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,19730,98,1.01 [0.52-2.00],0.9668453980760128
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,19627,96,0.68 [0.38-1.20],0.1802740697128038
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,22465,108,0.94 [0.72-1.23],0.6619971431676139
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,19188,99,1.07 [0.83-1.37],0.6141207140110156
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,22564,113,1.00 [0.89-1.13],0.9974359865486032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,19040,95,1.12 [0.85-1.46],0.4246780509541844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,22868,115,1.20 [0.80-1.78],0.3760094643707711
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,22645,116,1.13 [0.58-2.19],0.7162182287145229
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,19124,93,1.00 [0.77-1.29],0.9777609371587156
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,22649,117,0.96 [0.75-1.23],0.7655230328756878
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,22266,114,1.03 [0.82-1.29],0.7992491903653659
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,22105,111,0.91 [0.69-1.20],0.500798535824436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,22670,116,1.03 [0.85-1.24],0.7922189276156605
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",19040,95,1.00 [0.81-1.24],0.9758863182652364
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,22152,109,1.08 [0.81-1.43],0.5995356529545943
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,19186,95,1.25 [0.86-1.81],0.2335155980582148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,19693,96,1.21 [0.80-1.85],0.3700163986267231
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,22564,113,0.97 [0.73-1.29],0.8442393189354788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,19188,99,1.22 [0.83-1.80],0.3005194594411826
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,22152,109,0.98 [0.76-1.27],0.902899079865074
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,19188,99,0.97 [0.66-1.42],0.8567359712633325
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,22628,113,0.84 [0.59-1.19],0.3184413414036719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,19702,96,0.89 [0.69-1.15],0.3780750844752116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,22152,109,1.04 [0.71-1.52],0.8525783721810608
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,19632,95,0.95 [0.58-1.56],0.8334636756105959
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,22152,109,0.95 [0.77-1.18],0.6563937779106874
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,22868,115,1.02 [0.90-1.16],0.7404941483963638
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,22628,113,1.05 [0.78-1.42],0.7474342160449681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,19188,99,1.03 [0.78-1.35],0.8316063898326643
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,22868,115,0.94 [0.69-1.29],0.7114805606655235
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",19702,96,0.90 [0.65-1.25],0.5385816146055884
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,22266,114,1.01 [0.72-1.42],0.9415558334060316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,22679,117,1.51 [0.92-2.49],0.1028573002666738
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,19627,96,1.08 [0.70-1.67],0.7392436929389399
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,19206,96,1.81 [1.01-3.23],0.0459079959054123
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,19186,95,0.72 [0.50-1.03],0.0735865305979204
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,19632,95,0.85 [0.47-1.51],0.5705410078382933
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,19322,96,0.98 [0.69-1.39],0.9269772730877954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,19124,93,0.72 [0.47-1.10],0.1267829789291399
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,19693,96,1.09 [0.68-1.73],0.724181283490714
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,19732,96,1.00 [0.77-1.31],0.9770464723480878
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,19353,94,0.90 [0.74-1.08],0.2653000592350292
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,22564,113,1.00 [0.87-1.15],0.9891464426485076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,20133,103,1.28 [0.71-2.30],0.4087763041093725
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,19627,96,1.14 [0.70-1.88],0.5951224868014149
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,22564,113,1.28 [0.80-2.03],0.3022979299187737
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,19040,95,1.37 [1.11-1.68],0.0028722941290677
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,19647,98,0.81 [0.52-1.25],0.3403786381338934
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,22241,113,1.09 [0.85-1.38],0.5019578905564661
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,19353,94,1.08 [0.80-1.46],0.6246517458011769
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,22105,111,0.93 [0.75-1.15],0.4975837512390607
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",19186,95,1.14 [0.92-1.42],0.2371409428120463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",19627,96,0.83 [0.48-1.42],0.486821448962872
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,19693,96,0.86 [0.63-1.18],0.3538919727849339
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,22105,111,0.78 [0.52-1.16],0.2108799500619673
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,22564,113,0.92 [0.76-1.11],0.3912615538273742
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,22628,113,0.88 [0.71-1.10],0.2541261678317519
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,19322,96,1.08 [0.86-1.35],0.5119409854880129
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,22514,109,0.96 [0.81-1.14],0.6481906405972597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,22514,109,0.94 [0.76-1.16],0.5566388890295604
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,22152,109,1.03 [0.84-1.25],0.7965832563754724
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,19186,95,1.02 [0.69-1.52],0.9102588827276312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,22475,109,0.94 [0.78-1.13],0.4910502849280231
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,22266,114,0.98 [0.80-1.21],0.8835878928800697
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,19327,97,0.74 [0.41-1.34],0.3171775509030575
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,22901,116,1.26 [0.76-2.08],0.3731706432129857
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,19732,96,1.20 [0.66-2.18],0.5455993709269766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,19353,94,1.07 [0.79-1.46],0.66148779922814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,19732,96,0.91 [0.47-1.77],0.7765351418114734
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,22105,111,0.96 [0.85-1.08],0.4944788644196053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",19186,95,1.06 [0.66-1.72],0.8015133989365417
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,19627,96,0.86 [0.62-1.18],0.3398687543340518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,22105,111,0.97 [0.79-1.18],0.7385789320210067
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,19133,94,0.91 [0.57-1.48],0.7140653778571925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,22740,117,0.85 [0.39-1.83],0.6759444199601307
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,19188,99,1.88 [1.14-3.10],0.0136010988672224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,19317,94,1.06 [0.88-1.26],0.5553032131391388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,19186,95,1.21 [0.73-1.99],0.4607651219578621
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,19353,94,0.84 [0.49-1.46],0.5417245116152685
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,19764,99,0.41 [0.17-1.00],0.0488858258489683
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,19124,93,1.05 [0.76-1.46],0.7491768292605794
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,22568,116,1.29 [1.07-1.55],0.0072622250451428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,22734,116,1.36 [1.04-1.79],0.0269809729503568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,22629,117,1.31 [0.98-1.73],0.06413135777858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,22589,118,1.15 [0.68-1.92],0.6056937603585799
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,22667,116,1.19 [0.81-1.77],0.3792982638897029
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,22746,118,0.78 [0.50-1.22],0.2757448175413979
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,19627,96,1.02 [0.86-1.19],0.8452262679681826
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,22628,113,1.08 [0.76-1.52],0.6711263285107764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,22878,116,1.07 [0.69-1.64],0.7673653271800445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,19627,96,1.14 [0.80-1.62],0.4667523305540401
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,22511,117,1.04 [0.57-1.91],0.8957845022237443
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,19188,99,1.43 [0.72-2.87],0.3082546174279271
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,22740,117,1.11 [0.66-1.85],0.7004125494558824
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,22941,117,0.98 [0.59-1.61],0.9230677212516196
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,22640,116,0.86 [0.70-1.07],0.1757630472891087
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,19739,99,1.39 [0.67-2.87],0.370423327685859
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,19002,95,0.83 [0.64-1.08],0.173419543455681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,22670,116,1.05 [0.58-1.91],0.8633578929958351
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,22679,117,2.06 [1.43-2.98],0.0001170920717716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,22657,118,1.02 [0.71-1.47],0.9057489623645284
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,22566,115,1.13 [0.66-1.93],0.6576007096920907
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,22266,114,0.97 [0.63-1.50],0.8958932936228442
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,19133,94,1.06 [0.91-1.24],0.4644948437512735
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,19043,98,0.97 [0.55-1.74],0.930733370196148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,19600,96,0.86 [0.69-1.08],0.1927934251995493
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,22868,115,1.60 [0.90-2.84],0.1081133193668141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,22025,114,1.03 [0.90-1.18],0.6716557012429123
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,22941,117,0.99 [0.67-1.46],0.9676358096942754
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",22056,110,0.95 [0.66-1.37],0.7930272788618513
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,19353,94,0.91 [0.52-1.60],0.7451083097203526
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,22734,118,1.26 [0.88-1.82],0.2091439861145591
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,19732,96,0.92 [0.56-1.51],0.7409086594393997
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,19693,96,0.93 [0.74-1.17],0.5582453123851605
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,22398,117,1.76 [1.03-3.00],0.0373273420562218
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,19732,96,0.91 [0.40-2.10],0.8311283265031976
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,22774,117,0.99 [0.88-1.12],0.8801416208416315
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,22679,117,1.02 [0.69-1.52],0.9086588840532372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,22595,116,0.66 [0.31-1.41],0.2843643097640834
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,22740,117,0.90 [0.74-1.10],0.3147616354659971
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,19124,93,0.92 [0.57-1.50],0.7421018663786138
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",19353,94,0.84 [0.51-1.37],0.4751465781003964
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,19188,99,1.47 [0.75-2.90],0.2655076929845472
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,19353,94,1.71 [0.74-3.97],0.2079901631248009
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,22918,116,1.07 [0.82-1.40],0.6238714052627623
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,19188,99,1.40 [0.77-2.55],0.2684057887276448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,19186,95,0.84 [0.57-1.25],0.3969271839800179
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,19353,94,0.93 [0.64-1.35],0.6875000891138565
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,19133,94,1.36 [1.08-1.71],0.0090958093771277
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,19133,94,1.17 [0.87-1.56],0.3035396729118962
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,19632,95,0.93 [0.77-1.12],0.4294602044676908
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,19627,96,1.10 [0.84-1.44],0.4713441305263319
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,19233,94,1.39 [1.05-1.83],0.0222030019829316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,19702,96,1.00 [0.65-1.55],0.9988922450200912
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,19040,95,1.17 [0.75-1.85],0.4894934772722207
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,19124,93,1.07 [0.84-1.36],0.5678448269218005
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,19652,96,1.05 [0.64-1.72],0.8431413744158686
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,22564,113,1.17 [0.98-1.40],0.0874958792460917
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,22406,109,1.14 [0.73-1.78],0.5710086728521508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,22679,117,1.04 [0.83-1.30],0.7234960974282355
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,22734,118,0.84 [0.60-1.19],0.3254307352538358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,22225,114,1.29 [0.96-1.74],0.0957414148978685
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,19632,95,0.97 [0.64-1.48],0.8940503518346883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,22241,113,1.01 [0.64-1.58],0.9758813849604808
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,19322,96,1.15 [0.85-1.55],0.3704696967024329
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22514,109,1.89 [1.30-2.75],0.000924681797971
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22514,109,1.26 [0.98-1.62],0.0682016718057976
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,22701,114,0.72 [0.53-0.99],0.0440523074646815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,22918,116,1.47 [0.97-2.22],0.0692798430995567
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22663,115,1.10 [0.63-1.95],0.7310992227297515
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,22740,117,1.15 [0.71-1.85],0.5644600568211333
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22706,116,1.46 [0.88-2.42],0.1458737232397681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,22241,113,0.99 [0.65-1.50],0.9474724562980668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22706,116,1.36 [0.79-2.34],0.2594851427985641
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19322,96,1.13 [0.70-1.85],0.6146205126038178
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,22868,114,1.24 [0.73-2.09],0.4332979595541087
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22679,117,1.90 [1.13-3.19],0.0157656057553668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22679,117,1.30 [0.92-1.83],0.1307266574559802
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,22868,115,1.43 [0.78-2.61],0.245122300861477
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,22878,116,1.65 [1.11-2.47],0.0140282954982503
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22514,109,1.40 [1.07-1.83],0.0133228898602159
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,22868,115,1.23 [0.87-1.73],0.2465715808682358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22514,109,1.32 [0.87-1.99],0.185857329018357
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,22918,116,0.85 [0.45-1.60],0.611525285743872
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,22628,113,1.11 [0.84-1.46],0.4736790993213748
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,22918,116,0.65 [0.37-1.16],0.146480020879395
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,22774,117,1.25 [0.67-2.33],0.4816361879184229
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,22902,117,1.80 [1.12-2.91],0.0156611646576382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,22514,109,1.06 [0.79-1.42],0.6857262695032053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,19730,98,0.73 [0.42-1.27],0.2678457132532515
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,19693,96,0.88 [0.71-1.11],0.2816293762070806
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,19730,98,0.98 [0.63-1.52],0.9274019115819864
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",22266,114,1.23 [0.99-1.53],0.0604676281752414
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,19353,94,0.85 [0.48-1.52],0.5853470964022929
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,22514,109,0.90 [0.60-1.34],0.5980845936455611
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,22679,117,0.84 [0.44-1.62],0.6018562447384909
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,19732,96,0.97 [0.75-1.25],0.8171453725703136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,19632,95,0.98 [0.81-1.18],0.7996543150429195
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",19040,95,0.97 [0.65-1.45],0.8779937796029732
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,19188,99,0.99 [0.77-1.26],0.911082211903429
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,19233,94,0.82 [0.54-1.23],0.3378252659620025
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,22152,109,1.17 [0.78-1.74],0.4456310814348942
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,19188,99,0.95 [0.76-1.19],0.6536616807609468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,18899,95,1.34 [0.93-1.92],0.1129588535192846
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,22266,114,0.86 [0.49-1.50],0.5892313953697267
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,19186,95,1.16 [0.66-2.04],0.6076733969449786
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,19186,95,1.23 [0.82-1.86],0.3141017273402688
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,19322,96,1.06 [0.88-1.27],0.5417168915790309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,19732,96,0.67 [0.33-1.38],0.276682578273645
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,19133,94,1.21 [0.79-1.84],0.3852746374451244
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,22152,109,0.92 [0.73-1.17],0.508114064840983
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,22520,115,1.25 [0.90-1.75],0.1887290099252989
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,19353,94,1.06 [0.84-1.34],0.6333299347664032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,22105,111,0.57 [0.34-0.96],0.0358512894472778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,19133,94,0.99 [0.66-1.47],0.949964052936246
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,19040,95,0.93 [0.66-1.30],0.655031324742714
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,22881,116,1.16 [0.85-1.59],0.3391181366016164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,19702,96,0.96 [0.56-1.62],0.8696857928326347
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,19188,99,2.30 [1.43-3.71],0.0005844705157563
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,22241,113,1.00 [0.77-1.29],0.9708440384233452
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,22628,113,0.88 [0.69-1.11],0.27424151863899
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",19188,99,0.95 [0.56-1.64],0.8615402721846449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,19133,94,1.00 [0.66-1.52],0.9863626753620874
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,19353,94,1.00 [0.80-1.26],0.9749815842319112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,19730,98,1.01 [0.78-1.31],0.9236526334859568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,22663,115,1.14 [0.83-1.56],0.4274806090066153
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,19739,99,1.10 [0.77-1.57],0.6156816571135546
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,22679,117,0.86 [0.52-1.42],0.5526814413249548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,22868,114,0.94 [0.72-1.22],0.6293369051532614
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,22628,113,0.86 [0.71-1.04],0.1180676739075224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,19310,94,0.84 [0.61-1.16],0.2841542686705599
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,19632,95,0.97 [0.81-1.16],0.7473808443153122
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,19040,95,0.99 [0.70-1.39],0.958828288708194
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,19186,95,1.13 [0.87-1.48],0.3590980732102276
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,22628,113,0.96 [0.79-1.17],0.6886080481374433
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,19627,96,1.04 [0.83-1.29],0.7478605222782926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,19133,94,0.97 [0.64-1.46],0.8850561910527899
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,19188,99,1.10 [0.87-1.40],0.4373782863763137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,19702,96,0.87 [0.64-1.18],0.3605178328988967
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,22670,116,0.88 [0.73-1.06],0.1883342077092489
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,22266,114,0.97 [0.74-1.27],0.8260690015066279
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,19133,94,0.67 [0.40-1.13],0.1333351607474541
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,22266,114,1.01 [0.56-1.82],0.977611279399374
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,19133,94,1.04 [0.71-1.51],0.8576335613649829
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,19124,93,1.11 [0.91-1.34],0.3012950814143668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,19632,95,0.81 [0.66-0.98],0.028619638640455
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,19188,99,0.97 [0.60-1.57],0.917185976870213
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,22067,111,1.02 [0.81-1.27],0.8848604319931129
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,19186,95,1.17 [0.79-1.72],0.4346769974359054
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TTN,Titin,19133,94,1.30 [1.04-1.63],0.019506234564316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,19539,99,1.05 [0.49-2.26],0.8954348962194657
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,19124,93,0.64 [0.31-1.33],0.2310745068590279
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,19730,98,0.93 [0.73-1.17],0.5253172164323039
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,19353,94,0.96 [0.74-1.25],0.7801889095812522
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,22514,109,1.00 [0.82-1.21],0.9760632632451478
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,19396,97,0.91 [0.58-1.43],0.6809106786429591
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,22740,117,1.11 [0.61-2.00],0.7384317748659135
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,22868,115,1.13 [0.89-1.44],0.3241095289976359
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,19693,96,0.91 [0.62-1.33],0.6163378092637164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,19088,93,1.05 [0.86-1.27],0.6428594699623138
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",22679,117,0.97 [0.68-1.38],0.8656904852053511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,22523,115,1.09 [0.85-1.40],0.4891918586352254
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,22670,116,0.68 [0.38-1.21],0.1864777594088122
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",19188,99,1.03 [0.76-1.40],0.8364615444016655
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,22564,113,0.70 [0.44-1.12],0.1336280568232354
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,19627,96,1.03 [0.54-1.99],0.918142910004104
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,19732,96,1.01 [0.73-1.38],0.968602893610661
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,19188,99,1.30 [0.99-1.71],0.05813379512556
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,19133,94,0.84 [0.51-1.38],0.4858466289304595
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,19322,96,1.06 [0.80-1.41],0.6670158889939511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,19632,95,0.95 [0.82-1.09],0.4666725563497339
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,19133,94,1.05 [0.87-1.26],0.6398294050649924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,19133,94,0.89 [0.49-1.61],0.6986178840435788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,22514,109,1.69 [1.10-2.61],0.0163659552432043
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,22876,116,0.83 [0.62-1.10],0.198855283889248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,19188,99,1.01 [0.48-2.15],0.9711335417362316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,19040,95,0.98 [0.69-1.39],0.9042536408865318
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,19627,96,1.37 [0.83-2.26],0.2150116322781892
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,19732,96,1.03 [0.83-1.27],0.806372966677958
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,19124,93,1.45 [1.05-2.00],0.0226418478987226
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,19324,93,1.02 [0.72-1.43],0.931981059947111
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,19322,96,1.08 [0.82-1.42],0.5852643723135212
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,19186,95,0.95 [0.71-1.28],0.7513774263973819
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,22564,113,1.02 [0.85-1.22],0.845663427023564
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,19627,96,0.87 [0.66-1.14],0.3077349223909014
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,19693,96,0.89 [0.51-1.56],0.6863010072686827
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,19133,94,0.99 [0.78-1.26],0.9495984319173038
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,22266,114,1.04 [0.87-1.23],0.6680198385735727
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,22152,109,1.02 [0.74-1.39],0.915122919720316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,22266,114,1.01 [0.75-1.34],0.9701065007673276
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,19188,99,0.97 [0.78-1.21],0.8183840992963571
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,22628,113,0.97 [0.79-1.18],0.7335146353038007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,22285,116,1.20 [0.65-2.22],0.5582143226070599
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,19739,99,1.02 [0.78-1.33],0.8822276044614626
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,22564,113,0.45 [0.19-1.05],0.0660136560149251
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,19124,93,0.97 [0.79-1.19],0.774093787635469
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,22697,118,1.36 [0.74-2.48],0.3209197062465037
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,22868,115,1.32 [0.77-2.26],0.3191986139735934
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,19040,95,0.89 [0.69-1.16],0.3997069052966554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,22849,116,1.27 [0.98-1.66],0.0721686545628167
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,19188,99,0.98 [0.49-1.94],0.9547798006116092
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,22740,117,1.07 [0.80-1.43],0.6527080470793019
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,22878,116,0.92 [0.56-1.49],0.7226266169214095
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,19702,96,0.97 [0.51-1.83],0.9194459867627028
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,22266,114,0.88 [0.78-1.00],0.0529335480938485
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,19233,94,0.87 [0.39-1.95],0.7324985994878918
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,19732,96,1.35 [0.78-2.32],0.2799529901652479
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,22564,113,1.01 [0.79-1.30],0.9105865700885444
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,19739,99,0.97 [0.75-1.26],0.835881060410544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,22564,113,1.05 [0.72-1.52],0.80826323949628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,19353,94,0.93 [0.69-1.26],0.6441810873844721
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,22564,113,1.01 [0.82-1.24],0.921359920253548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,19627,96,0.94 [0.76-1.15],0.5319212906344442
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,22564,113,1.00 [0.80-1.24],0.9648792506309616
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,19627,96,0.94 [0.53-1.69],0.8453353039145798
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,19133,94,1.57 [0.95-2.59],0.0765070935028303
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,19627,96,1.24 [0.92-1.67],0.1635597852422071
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,22645,116,1.37 [0.91-2.05],0.1313715844116472
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,22635,116,1.05 [0.81-1.36],0.7171483402813331
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,19693,96,1.21 [0.73-1.99],0.461232016340485
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,22105,111,0.82 [0.57-1.16],0.2606362479679744
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,19353,94,0.85 [0.51-1.42],0.5264421807557216
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,22266,114,1.09 [0.84-1.43],0.5110882507828323
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,22868,115,1.03 [0.82-1.29],0.8071475784285084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,22152,109,0.95 [0.54-1.68],0.856327001024648
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,19322,96,0.98 [0.70-1.37],0.8906814188857528
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,22829,114,1.32 [0.89-1.94],0.1642812352416491
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,19040,95,0.82 [0.60-1.12],0.2169248022531797
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,22430,108,1.24 [0.80-1.92],0.3418657383705349
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,19702,96,0.46 [0.24-0.89],0.0207764527462271
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,22941,117,0.90 [0.72-1.12],0.3321591930163769
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",22679,117,1.23 [0.80-1.90],0.3396163437512681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,22241,113,1.00 [0.78-1.27],0.983873807466195
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,22266,114,1.03 [0.86-1.23],0.7460902756110663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,22105,111,0.93 [0.76-1.13],0.4510856056017528
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,19693,96,0.85 [0.65-1.12],0.2596572911890716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,19188,99,1.23 [0.95-1.58],0.109432136899702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,19627,96,0.78 [0.43-1.41],0.4135310882931989
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,19241,95,0.92 [0.62-1.37],0.6977164690228793
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,22840,114,0.93 [0.72-1.20],0.5662551167721201
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,21498,108,1.41 [0.92-2.15],0.1137981466426728
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22452,109,0.66 [0.43-1.00],0.048474318205976
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",22706,116,0.88 [0.55-1.41],0.6012053957843866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,22868,114,0.74 [0.46-1.20],0.2222111743931241
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,22241,113,1.10 [0.62-1.97],0.7421205031796391
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,22514,109,0.86 [0.63-1.18],0.3570081436031337
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,22868,114,0.92 [0.68-1.25],0.6151846815559011
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,22827,117,1.15 [0.67-1.96],0.6156242718208387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,19188,99,1.20 [0.86-1.66],0.283404413250362
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,22740,117,0.97 [0.80-1.17],0.7303939002274693
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,22105,111,1.05 [0.67-1.66],0.8204881637547322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,19693,96,1.76 [0.90-3.45],0.0976823652961733
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",19632,95,0.98 [0.86-1.12],0.7821651174640438
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,22564,113,1.02 [0.88-1.18],0.7842128250941188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,19627,96,0.67 [0.35-1.26],0.2138220625215361
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,19133,94,0.91 [0.67-1.25],0.5654302862873133
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,22241,113,0.93 [0.76-1.13],0.44489327520883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,19322,96,1.09 [0.83-1.42],0.5438616165730477
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,19188,99,1.88 [1.05-3.38],0.0341876375330414
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,19188,99,1.35 [0.93-1.97],0.1124717031909441
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,22152,109,1.03 [0.81-1.31],0.836354943786507
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,22266,114,1.17 [0.82-1.68],0.3894523898523526
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,19133,94,1.09 [0.82-1.46],0.5365863804041002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,19632,95,0.93 [0.75-1.16],0.5289248261808766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,19693,96,0.62 [0.28-1.36],0.2345042559937151
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,19188,99,1.12 [0.72-1.75],0.612910715837385
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,19353,94,1.11 [0.83-1.48],0.4753303607081104
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,19627,96,1.15 [0.92-1.43],0.2155765191710939
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,19632,95,0.94 [0.71-1.26],0.6969072206462208
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,19627,96,1.27 [0.92-1.75],0.152388784070059
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,19233,94,1.04 [0.96-1.12],0.3162434349600173
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,19040,95,1.13 [0.69-1.86],0.6312582844721041
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,19124,93,1.09 [0.91-1.31],0.3345788106684275
